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ABSTRACT

Alok Sharma, Ph.D., Biomedical Sciences PhD. Program, Wright State University, 2011.
Son is Essential for Nuclear Speckle Organization, Cell Cycle Progression and PremRNA Splicing.

Nuclear speckles provide important spatial organization and dynamic regulation
for pre-mRNA processing factors in mammalian cells. While the nuclear speckle
proteome is complex, little is known at the molecular level about how these factors are
organized into nuclear speckles or how alterations in the organization of these factors
impacts gene expression. We have discovered a new function for a large (2564 amino
acid) nuclear speckle protein called Son in maintaining the organization of pre-mRNA
processing factors in nuclear speckles. Depletion of Son by RNAi causes snRNP and
serine-arginine rich (SR protein) splicing factors to undergo dramatic disorganization into
doughnut-shaped nuclear speckles.

Rescue of the disorganized nuclear speckle

phenotype requires a region of Son with multiple tandem repeat motifs that are unique to
Son. This demonstrates that the tandem repeats of Son are necessary for appropriate
localization of pre-mRNA processing factors, and it suggests a potential role for Son as a
nuclear speckle scaffold. Surprisingly, in addition to its nuclear functions, Son depletion
also results in decreased cell proliferation due to growth arrest in mitosis. Son is critical
for promoting the transition from metaphase to anaphase. Son is therefore essential for
nuclear organization and function, as well as for normal cell cycle progression.
Son is the largest SR protein, and as such it likely has roles roles in pre-mRNA

splicing, either at transcription sites or in splicing complex assembly in nuclear
speckles.We examined splicing on a stably integrated beta-tropomyosin minigene locus
in Son-depleted cells. Immunofluorescence/RNA-FISH indicated that Son localizes at
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this minigene locus. While Son depletion did not alter mRNA levels or constitutive
splicing of beta-tropomyosin reporter transcripts, alternative splice site selection was
altered. To identify endogenous human splicing targets of Son, we compared splicing
output in control versus Son-depleted HeLa cells by quadruplicate screening on
Affymetrix Exon Array 1.0 ST. Our data suggest that Son-regulated splicing
encompasses all known types of alternative splicing, the most prominent being
alternative splicing of cassette exons. Results from array validation experiments show
that Son is essential for appropriate splicing of transcripts encoding chromatin modifiers.
Other putative splicing targets for Son have functions in fundamental cellular pathways
such as integrin-mediated cell adhesion, cell cycle, cholesterol biosynthesis, and
apoptosis.
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CHAPTER 1
Introduction
Transcription of genes by RNA polymerase II (RNA Pol II) results in
production of pre-messenger RNA (pre-mRNA). This pre-mRNA is processed
into mature RNA (mRNA) co-transcriptionally (Moore et al., 2009; Perales et al.,
2009), by addition of a 5` 7-methylguanosine cap, splicing of the introns and
polyadenylation of the 3` end. These processing events are coupled to gene
transcription and are considered an essential regulatory mechanism important for
mRNA stability, as well as for nuclear export of mRNA (Moore et al., 2009;
Perales et al., 2009). The pre-mRNA processing machineries are multimolecular
complexes that assemble on the C-terminal domain (CTD) of the large subunit of
RNA Pol II. The RNA pol II CTD acts as a “seed” for stepwise assembly of these
complexes, ensuring that all RNA Pol II pre-mRNA transcripts are processed to
mRNA (Bentley, 2005; Kornblihtt, 2006; Maniatis et al., 2002; Neugebauer,
2002). Deletion of the CTD impaired the processing of the pre-mRNA transcribed
(McCracken et al., 1997; Misteli et al., 1999), demonstrating the importance of
the CTD for coupling transcription and splicing. It is accepted that the
phosphorylation status of the serines in the heptad YSPTSPS, a motif that is
repeated 52 times in the CTD, plays an important role in regulating sequential
loading of processing factors onto pre-mRNAs while transcription is in progress
(Moore et al., 2009; Perales et al., 2009). It is also known that in mammalian
cells, these processes occur in the nucleus, and the processed mRNAs are
exported to the cytoplasm for translation into protein.
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In recent years, there has been an increased understanding about the
structural organization of the nucleus and how it influences the coupled process
of pre-mRNA transcription and processing. Intracellular organelles generally
provide spatial organization to create functionally distinct compartments. This is
seen in the cytoplasm where distinct processes are organized inside membrane
bound compartments such as mitochondria, Golgi apparatus, and endoplasmic
reticulum (Spector, 1993). The nucleus has no membrane-bound structures, but
it is organized into various sub-nuclear compartments (Spector, 1993). The
nucleolus is one such compartment that provides a great example for how spatial
organization streamlines biochemical function; namely, ribosome biogenesis. The
nucleoli form at nucleolar organizer regions (tandem repeats of rRNA genes),
where ribosomal DNA repeats are transcribed to produce a pre-ribosomal RNA.
Pre-rRNA processing occurs co-transcriptionally in the nucleolus, and rRNA
assembly into mature small and large ribosomal subunits occurs in immediately
adjacent nucleolar regions. By organizing the entire pathway of ribosome
biogenesis into a single sub-nuclear region, it is likely that the entire process
occurs more efficiently (Lamond et al., 2003). In addition to the nucleolus, the
mammalian cell nucleus has other sub-compartments such as promyelocytic
leukemia (PML) bodies, Cajal bodies and nuclear speckles. No apparent function
is known for PML bodies, but they are often observed near Cajal bodies and
have been suggested to play a role in regulating transcription (Brouwer et al.,
2009; Dundr et al., 2001). Cajal bodies are enriched with coilin (Matera, 1998).
These bodies are involved in maturation and assembly of small nucleolar RNAs
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(snoRNAs) and small nuclear ribonucleoproteins (snRNPs) (Matera, 1998; Cioce
& Lamond, 2005). snRNPs are also found in nuclear speckles, which are
storage/assembly sites for pre-mRNA processing factors (Lamond & Spector,
2003).
Nuclear Speckles
When sections of rat liver were immunolabeled with serum from
individuals suffering from autoimmune diseases, antibodies labeled 20-50
regions within the nucleus, which were termed “nuclear speckles” (Lamond &
Spector, 2003). Nuclear speckles were previously observed by electron
microscopy to occur in a “cloud” of RNA and were termed interchromatin
particles (Lamond & Spector, 2003). Later when localization of splicing factors to
the nuclear speckles was observed by electron microscopy, the speckled pattern
corresponded to two nuclear structures: interchromatin granule clusters (IGCs)
which are the equivalent of nuclear speckles, and perichromatin fibrils (PFs)
which are the equivalent of transcription sites (Spector et al., 1991). IGCs consist
of 20-25 nm granules that are interconnected by thin fibrils (Lamond & Spector,
2003). The presence of polyadenylated RNA in nuclear speckles initially
suggested that these may be sites of transcription (Carter et al., 1991; Carter et
al., 1993). Also, specific gene transcripts colocalized to nuclear speckles and to
their periphery, indicating that nuclear speckles could be sites of transcription
and processing of pre-mRNA (Xing et al., 1993; Xing et al., 1995; Smith et al.,
1999; Shopland et al., 2002; Shopland et al., 2003). However, [3H]-uridine
labeling indicated that transcription does not occur in IGCs (Fakan et al., 1980).
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On the other hand, PFs at the IGC periphery could incorporate [3H]- uridine
pulses, suggesting that these regions contained transcription sites (Fakan, 1994).
This was further supported by 5-bromouridine 5'-trisphosphate (BrUTP)
incorporation experiments that showed nascent transcripts at the periphery of the
nuclear speckles and all throughout the nucleus (Cmarko et al., 1999). It was
also observed that splicing factors were recruited from nuclear speckles to
transcription sites, first in cases of viral infection when viruses formed
transcription factories that occupied large nuclear regions (Jimenez-Garcia et al.,
1993) and later following transient transfections of cells with plasmids that also
form large transcription factories in nuclei (Huang et al., 1996). The most
convincing evidence comes from live cell microscopy observations that
fluorescently labeled speckle components are recruited from nuclear speckles to
active sites of transcription (Misteli et al., 1997).
The recruitment of the nuclear speckle components is dependent on
transcription activation as shown by experiments using an inducible pem gene
locus. The pem gene locus acquired nuclear speckle components (splicing
factors) only when the locus was transcriptionally active (Misteli et al., 1998).
Also, truncation of the carboxy-terminal domain (CTD) of the large subunit of
RNA polymerase II (RNA Pol II) prevented the localization of nuclear speckle
components to the induced pem gene locus, suggesting a role for RNA Pol II
CTD in the recruitment of nuclear speckle components to transcription sites
(Misteli et al., 1999). The predominant view is that nuclear speckles (IGCs) are
storage sites for pre-mRNA processing factors and are not centers for co-
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transcriptional processing (Lamond & Spector, 2003). However, it is possible
that some gene loci coincide with nuclear speckles or that very active gene loci
may recruit enough splicing machinery to resemble a nuclear speckle. These
data also pointed to a highly dynamic flux of RNA processing factors among
multiple nuclear locations.
Nuclear Speckle Dynamics
Nuclear speckles are positionally stable structures as compared to other
more mobile nuclear compartments such as PML bodies or Cajal bodies.
However, nuclear speckles are very dynamic at their periphery (Misteli, 2000).
Nuclear speckles are also dynamic with regard to their disassembly during
mitosis and and assembly in daughter nuclei. During the cell’s entry into mitosis
when the nuclear envelope breaks down for the division of genetic material,
nuclear speckle components diffuse throughout the cytoplasm (Ferreira et al.,
1994; Prasanth et al., 2003; Spector et al., 1986; Thiry, 1995). During mitosis, the
speckle components localize in small structures called mitotic interchromatin
granules (MIGs) that form at metaphase (Ferreira et al., 1994; Prasanth et al.,
2003) and are similar in structure to the IGCs (Thiry, 1995). MIGs increase in
number and size through telophase. During late telophase, after formation of the
nuclear envelope, the RNA Pol II gene expression machinery enters the nucleus
sequentially (Prasanth et al., 2003). SR proteins such as SF2/ASF, SC35 and the
snRNPs enter the daughter nuclei prior to the RNA pol II subunits (Prasanth et
al., 2003). Since nuclear speckles are not membrane bound structures, it has
been proposed that nuclear speckles are assembled by the “self association” of
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nuclear speckle components (Misteli, 2000). In part this is due to interactions
between the arginine-serine (RS) rich domains found in serine arginine (SR)
proteins (Caceres et al., 1997; Fu, 1995; Hedley et al., 1995; H. Li et al., 1991).
Hyperphosphorylation of components of nuclear speckles by overexpression of
Clk/STY resulted in diffused nuclear localization of splicing factors. These cells
did not have intact IGCs and also showed defects in coordination in transcription
and splicing (Sacco-Bubulya et al., 2002). This suggests that maintaining the
structural integrity of nuclear speckles is important for coupling of transcription
and processing. Mechanisms other than regulation by phosphorylation or self
association of nuclear speckle components may contribute to nuclear speckle
structural organization. The results of this dissertation will show that Son is
important for maintaining structural integrity of nuclear speckles.
Nuclear Speckles Components
Many of the nuclear speckle components were initially identified when
fluorescence microscopy revealed their subnuclear localization in nuclear
speckles. Components identified by this approach include a stable pool of
polyadenylated RNA (Carter et al., 1991; Carter et al., 1993; Huang et al., 1991)
and complexes involved in pre-mRNA splicing such as snRNPs (U1,U2, U4, U5
and U6) and SR proteins such as splicing factor 2/alternative splicing factor
(SF2/ASF) and SC35 (Lamond & Spector, 2003). A proteomic analysis of mouse
liver nuclear speckles identified 146 proteins (Mintz et al., 1999; Saitoh et al.,
2004), a majority of which are involved in pre-mRNA processing functions such
as capping, splicing, and polyadenylation. The proteomic analysis also revealed
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33 novel nuclear speckle proteins, most of which remain to be validated (Mintz et
al., 1999; Saitoh et al., 2004). Among these novel proteins was Son, which is the
focus of this dissertation.
SR Proteins
SR proteins are a class of nuclear proteins that have a stretch of arginine
and serine dipeptide repeats (RS domain) which has been implicated as a
nuclear speckle targeting sequence (Caceres et al., 1997; Fu, 1995; Hedley et
al., 1995; H. Li et al., 1991). Some SR proteins also have one to three RNA
recognition motifs (RRMs) (Birney et al., 1993; Zahler et al., 1992) implicated in
identifying splice sites within the pre-mRNA (Caceres et al., 1997; Zahler et al.,
1993). The serine residues of the RS domain can be phosphorylated by several
kinases including SRPK1 (Gui et al., 1994), Clk/STY (Colwill et al., 1996), a
lamin-B receptor-associated kinase (Nikolakaki et al., 1996), and DNA
topoisomerase I (Rossi et al., 1996). Once phosphorylated by these kinases, the
SR proteins are recruited to the carboxy-terminal domain (CTD) of the largest
subunit of RNA polymerase II at the transcription sites and help in cotranscriptional splicing (Bentley, 2005; Egloff et al., 2008; Hirose et al., 2000;
Lewis et al., 2000; Misteli et al., 1999; Phatnani et al., 2004; Rosonina et al.,
2004). An example of this is SF2/ASF which gets phosphorylated to be released
from speckles and assembled into splicing complexes. Once splicing is
accomplished, SF2/ASF is dephosphorylated and helps in transport of the
processed mRNA to the cytoplasm, followed by nuclear re-import of SF2/ASF
and its targetinf to nuclear speckles{{198 Stamm,S. 2008}}. In addition to their
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involvement in constitutive and alternative splicing, numerous SR proteins have
roles in mRNA export, mRNA stability, and nonsense-mediated decay (Sanford
et al., 2005).

Coupling synthesis and processing of pre-mRNA
Gene expression of protein coding genes in mammalian cells consists of
two coupled processes: transcription of the pre-mRNA from the gene and premRNA processing which constitutes 5` end capping, removal of introns and
polyadenalyation of the 3` end of the pre-mRNA. Processing factors are loaded
co-transcriptionally from the CTD of the largest subunit of RNA Pol II onto the
pre-mRNA (Bentley, 2005; Egloff et al., 2008; Hirose et al., 2000; Lewis et al.,
2000; Misteli et al., 1999; Phatnani et al., 2004; Rosonina et al., 2004). RNA Pol
II CTD serves as a landing pad for all RNA Pol II interacting proteins, which
include pre-mRNA-processing factors and chromatin modifiers (Phatnani et al.,
2006). It consists of 52 heptad repeats of YSPTSPS and can bind multiple
proteins (Meinhart et al., 2005). The heptad repeats are phosphorylated and
dephosphorylated by kinases and phosphatases at the Ser 2, Ser 5, and Ser 7
positions in a manner that is coordinated with the initiation, elongation, and
termination phases of transcription (Meinhart et al., 2005; Phatnani et al., 2006).
Once transcription is initiated, Ser 7 is phosphorylated, the capping enzyme is
recruited to the early transcription complex through specific interactions between
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the Ser 5-phosphorylated CTD while Ser 2 phosphorylation is required for
splicing factors loading on the pre-mRNA {{199 Hirose,Y. 2007}}. 3′ end
processing is intimately coupled with transcription termination, in which the Pol II
elongation complex dissociates from the DNA template and releases the nascent
RNA when Ser 2 is dephophorylated {{199 Hirose,Y. 2007}}. Because pre-mRNA
splicing occurs co-transcriptionally on nascent RNA, this suggests that splicing
and transcription are temporally and mechanistically coupled (Kornblihtt et al.,
2004).

Pre-mRNA Splicing
Intron removal is an essential step for expression of most mammalian
protein coding genes. Within introns resides a 5` splice site (donor site), a 3`
splice site (acceptor site) and a branch site. The donor site marks the beginning
of an intron and usually has a “GU” nucleotide sequence while the acceptor site
which marks the 3` intron boundary ends with a “AG” nucleotide sequence. The
branch site has an “A” nucleotide. The sequence between the branch point and
the acceptor site is highly rich in pyrimidines and is called the polypyriminidine
tract. These nucleotides in the intron regions of a gene are thought to mark the
boundaries for its splicing by a multi-component complex called the spliceosome
(Jurica et al., 2003). There are two types of spliceosome: major and minor
spliceosomes. Almost 99% of intron splicing from pre-mRNA in mammalian cells
is performed by major spliceosomes. Studying pre-mRNA splicing in vitro shows
that activation of splicing is dependent on interactions between spliceosomal
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small nuclear ribonucleoproteins (snRNPs U1 and U2, and the U4-U6-U5 trisnRNP) and numerous non-snRNP splicing factors with the pre-mRNA (Krainer
et al., 1990; Mayeda et al., 1992; Caceres et al.; Burge C et al., 1999; Black,
2003). The major spliceosome is further divided into complexes which come
together to remove the intron and ligate the exons together. Intron and exon
boundaries are recognized by complex E of the splicesome. This complex
consists of U1 snRNPs (which bind to the GU donor site of the intron), U2AF
protein 35 (binds to the AG acceptor site), U2AF 65 (binds to the polypyrimidine
tract), branch binding protein (BBP) (binds to the branch point), heterogeneous
nuclear ribonucleoproteins (hnRNPs) and SR proteins. U2AF 35, U2AF 65 and
the BBP in turn recruit complex “A” which consists of the U2 snRNP to the
branch point A. These two complexes, E and A, basically mark the intron-exon
boundary for the other complexes of the major spliceosome and are termed the
exon definition complexes (Black, 2003; Jurica et al., 2003).
Intron-exon boundaries are recognized and marked by base-pairing
interactions between the pre-mRNA and the U1 and U2 snRNAs, respectively
(Black, 2003; Jurica et al., 2003). This selection process is influenced by
activities

of

non-snRNP

spliceosome

components.

SR

proteins

and

heterogeneous nuclear ribonucleoproteins (hnRNPs), are components of the
exon definition complexes, that can either enhance or suppress the interaction of
the U1 and U2 snRNPs with 5' or 3' splice sites, respectively (Krainer et al.,
1990; Mayeda et al., 1992 Eperon et al., 1993; Caceres et al., 1994; Black, 2003;
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Jurica et al., 2003). This is the major mechanism driving alternative splicing
choices on pre-mRNA in mammalian cells.
As soon as the A complex binds to the pre-mRNA, an ATP is hydrolyzed
and the B complex (U5, U4 and U6) is recruited. U5 binds to the exon at the 5`
splice site and U6 binds to U2. U5 then shifts from exon to intron and U1 is
released providing a binding site for U6 to the 5` splice site. The C complex is
formed where U4 is released from the B complex and U6/U2 perform a transesterification reaction that cleaves the 5` site of the intron and ligates it to the
branch point. In turn U5 binds to the 3` splice site and forms a lariat. U2/U5/U6
remain bound to the intron and a second trans-esterification step cleaves the 3`
splice site and ligates the exons using ATP hydrolysis completing the splicing
process (Black, 2003; Jurica et al., 2003). The lariat is then degraded by nonsense mediated decay and the splicing machinery is recycled to nuclear speckles
after it is dephosphorylated (Black, 2003; Jurica et al., 2003).

SR Proteins, hnRNPs and Alternative Splicing
Splicing enhancers and silencers are consensus sequences nucleotide
sequences that are recognized by RNA binding proteins. Competition of binding
influences splicing outcome. SR proteins enhance splice site recognition by
binding to exonic splicing enhancer regions (ESE) in exons (Zuo & Maniatis,
1996; Caceres et al., 1997; Liu et al., 1998; Liu et al., 1998; Mayeda et al., 1999;
Mayeda et al., 1999; Blencowe, 2000; Black, 2003; Jurica et al., 2003; Wang et
al., 2008) or to intron splicing enhancer regions (ISE) (Venables, 2007; Voelker
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et al., 2007; Wang et al., 2008) in introns of the nascent RNA. The RNA
recognition motifs (RRMs) of the SR proteins interact with ESEs and ISEs in
nascent RNA, while the RS domain is involved in recruiting the snRNPs to the
adjacent splice site by protein-protein interactions (Zuo & Maniatis, 1996; Liu et
al., 1998; Mayeda et al., 1999; Black, 2003; Jurica et al., 2003; Wang et al.,
2006). Individual SR proteins interact with the nascent RNA during spliceosome
assembly (Krainer et al., 1990; ; Fu et al., 1990; Zahler et al., 1992; Fu, 1995;
Black, 2003; Jurica et al., 2003) and enhance both the recruitment of U2AF 65
and U2AF 35 to the 3` splice site (Zuo & Maniatis, 1996) as well as recruitment of
U1 snRNP particles to the 5`splice site (Krainer et al., 1990; Eperon et al., 1993;
Kohtz et al., 1994). U2AF 65 in turn helps recruitment of U2 snRNP to the
branch point adenosine residue in the intron (Valcarcel et al., 1996; Zuo &
Maniatis, 1996). Exon splicing enhancers (ESEs) are very common and are
present in almost all mammalian exons (Liu et al., 1998).
Juxtaposed to the ESEs and ISEs within the pre-mRNA are cis elements
called exon splicing silencer regions (ESS) and intron splicing silencer regions
(ISS). These are binding sites for heterogeneous nuclear ribonucleoproteins
(hnRNPs) which are the spliceosome components that suppress splice site
recognition (Dreyfuss et al., 1993; Krecic et al., 1999; Wagner et al., 2001). Just
like the SR proteins, hnRNP proteins have a characteristic structure consisting of
RNA-binding domains and an auxiliary domain capable of protein–protein
interaction (Mayeda et al., 1992; Mayeda et al., 1994; Smith et al., 2000). Two
models suggest possible mechanisms for hnRNP binding to these regions. First,
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exon splicing can be silenced by a direct competition of the hnRNP protein
binding to an ESS or ISS, that overlaps and/or antagonizes the binding of SR
proteins to an adjacent ESE or ISE resulting in an alternative splicing event (Wu
et al., 1993; Caceres et al., 1994; Krecic et al., 1999; Damgaard et al., 2002;
Hayakawa et al., 2002; Jurica et al., 2003; Wang et al., 2008; Hua et al., 2008).
The other model suggests that excessive binding of hnRNPs to the ISS or the
ESS causes the pre-mRNA to loop out to form a secondary structure which
prevents the SR proteins from binding to an adjacent ESE or ISE, resulting in
exon skipping (Wagner et al., 2001) (Figure 1). The SR proteins and hnRNPs
have antagonistic functions. This was shown by in-vivo and in-vitro splicing
studies using HeLa cells transfected with several reporter minigenes and either
over-expression of SF2/ASF (SR protein) or hnRNPA1 (Caceres et al., 1994).
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Figure 1: Models currently accepted for alternative splicing.
SR proteins and hnRNPs have antagonistic competing roles in splice site
selection and are important components in the exon definition complex of the
spliceosome. Adapted and modified from (Black, 2003; Jurica et al., 2003)
If an SR protein binds to intron splicing enhancers or exon splicing enhancer
regions (ISE or ESE) it helps recruit other factors associated with the exon
definition complex such as U1 and U2 snRNPs that mark the intron to be spliced.
On the other hand if hnRNPs bind to exon splicing silencer (ESS) regions or
intron splicing silencer (ISS) regions, located close to the ESEs or ISEs
respectively, the hnRNPs block the binding of SR proteins and thereby hinder the
recruitment of exon definition complex factors and the intron is not spliced.
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Transfection of SF2/ASF in HeLa cells along with the thalassemic allele of
the beta-globin minigene (which has three cryptic alternative splice sites as
compared to the wild type beta globin gene) increased the selection of a proximal
5` splice site, promoting the inclusion of the exon, preventing abnormal splicing
(Caceres et al., 1994). The E1A reporter minigene has three alternative splice
sites which include a proximal 5` splice site that generates a 9S transcript, and a
3` distal splice site that generates a 13S transcript (Caceres et al., 1994). Cotransfection of E1A reporter minigene with SF2/ASF generated the 9S transcript;
on the other hand co-transfection of E1A reporter minigene with hnRNPA1
generated the 13S transcript (Caceres et al., 1994). My study showed that Son,
the largest SR protein, also plays an important role in splice site selection of
various endogenous pre-mRNAs.
Son
Son transcripts could be detected in all tissues by Northen blot (Sun et al.,
2001). The highest expression was seen in heart tissue and leukocytes, followed
by lymph node, spinal cord, ovary, testis, thymus, spleen, pancreas, placenta,
and brain. Weaker expression was seen in colon, small intestine, prostate,
kidney, skeletal muscle, liver, and lung (Sun et al., 2001). Son was the largest
SR protein identified in the proteomic analysis of nuclear speckles (Mintz et al.,
1999; Saitoh et al., 2004). One third of the primary amino acid sequence of Son
is made of unique novel repetitive sequences of several different types; for
example, the 10-mer with the consensus sequence of “ MDSQMLASST “ is
repeated 10 times (Saitoh et al., 2004; Sun et al., 2001). Son has an RS domain
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and also has putative RNA-binding motifs at its carboxy terminus that include a
glycine rich patch (G-patch) and a double stranded RNA binding domain
(DSRBD) (Saitoh et al., 2004) (Figure 2). Son localizes to nuclear speckles in
mammalian cells (Saitoh et al., 2004; Sharma et al., 2010; Wynn et al., 2000).
Son has been implicated to play an important role in cell cycle regulation. Son
depletion leads to an arrest in G2/M phase of the cell cycle (Ahn et al., 2008;
Sharma et al., 2010). Son was also found in the proteomic analysis of human
mitotic spindles (Sauer et al., 2005) and Son depletion leads to shortening of
microtubules (Rines et al., 2008). My results reported within Chapter 5 pinpoint
that Son depleted cells arrest in metaphase, suggesting that Son is an essential
protein for cell cycle progression (Sharma et al., 2010).
Scaffolding proteins are usually insoluble proteins; an example being the
nuclear envelope scaffolding proteins called lamins that provide structural
support for the nuclear envelope. Son was found in the proteomic analysis of
insoluble nuclear extracts (Takata et al., 2009) and was also confirmed by
immunoblotting of insoluble nuclear extracts (Sharma et al., 2010). Large repeatrich proteins such as Son have demonstrated scaffolding functions. An example
of such a repetitive domain rich protein is large subunit of RNA Pol II. The heptad
repeat of “YSPTSPS” in the largest subunit of RNA Pol II CTD provides a
scaffold for multimeric pre-mRNA processing complexes to load onto nascent
pre-mRNA at transcription sites (Hirose et al., 2000).
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Figure 2: Graphic representation of Son motifs
One third of the primary amino acid sequence of Son is made of novel repetitive
sequences that are not found in any other proteins, spanning from amino acid
334-1493. Each color line represents a type of repeat and the repetition of the
lines represents the number of times that repeat occurs in the amino acid
sequence. Son has an RS domain (yellow highlighted region) and also has
putative RNA binding motifs at its carboxy-terminus that include a glycine- rich
patch (G-patch) (blue) and double stranded RNA binding domain (red).
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Son also has tandem serine rich repeats that may be analogous to
repeats in RNA Pol II CTD (e.g. the 10-mer MDSQMLASST is repeated 10 times
in Son). Son could function as a linker molecule between individual granules in
IGCs and/or between splicing factor complexes by its repeat domain and
therefore may form a similar molecular scaffold. Perhaps Son multimerizes and
its repeats may allow binding of many different RNA processing factors just like
the repeats in the CTD of the largest subunit of RNA Pol II, as an additional level
of organization beyond “self-association” among nuclear speckle components
(Misteli, 2000) to form a nuclear speckle. Specific Aim 1 of my dissertation was
designed to address if Son is required for organizing RNA processing factors in
nuclear speckles.
Hypothesis and Specific Aims
Although an underlying scaffold for nuclear speckles was not observed
when speckle factors were hyper-phosphorylated and released from nuclear
speckles by over-expression of SR protein kinases (Sacco-Bubulya et al., 2002),
the serine rich repeat motifs similar to those found in the CTD of the largest
subunit of RNA Pol II is consistent with suggesting a role of Son to have a
molecular scaffold like organizing function. We hypothesized that the repeat
region of Son is required to organize various speckle components and
required to maintain the structural integrity of nuclear speckles.
1. To establish a role for Son in maintaining nuclear speckle integrity
a) To examine a role for Son in maintaining nuclear speckle integrity in vivo.
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b) To probe which regions of Son are important in maintaining speckle
integrity
Son repressed transcriptional activity of human hepatitis B virus (HBV) by
binding to its negative regulatory element (NRE) (Sun et al., 2001). Transient
overexpression of Son inhibited HBV virion production (Sun et al., 2001),
suggesting that Son might play a role at the level of transcription during gene
expression. Son has also been implicated in hampering viral replication of H1N1
virus by inhibiting the normal trafficking of the influenza virions to late endosomes
early in the infection (Karlas et al., 2010). A role for Son in pre-mRNA splicing
has been suggested by interaction of Son with a known splicing factor, SRrp53
(Cazalla et al., 2005). Moreover, Son itself is an SR protein and SR proteins are
implicated in splice site selection as they are a part of the exon definition
complex described above. These studies lead me to the second hypothesis
that Son may have a role in pre-mRNA transcription and/or splicing.
Specific aim 2 of my dissertation was designed to test if Son has a role in
transcription and splicing.
To investigate if Son has a role in pre-mRNA transcription and/or splicing
a) To investigate if Son has a role in transcription in-vivo.
b) To determine if Son has a role in pre-mRNA splicing in-vivo.
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CHAPTER 2
MATERIAL AND METHODS

cDNA Constructs
Son cDNA Constructs
The 3’ end of Son cDNA was PCR amplified from clone fh21047 (a partial
clone truncated at the 5’ end; Kazuza DNA Research Institute, Japan) and
subcloned into the truncated KIAA1019 (a partial clone truncated at the 3’ end;
Kazuza DNA Research Institute, Japan) in pBluescript to produce full length Son
cDNA. A PCR-strategy was used to place a BspEI site before the start codon of
full length Son for subcloning into pEYFP-C1. Full-length Son was cloned into
pEYFP-C1 as a BspE1 and SacII fragment (7.6 Kb) to obtain full length yellow
fluorescent protein-Son (YFP-Son Fl). A cDNA encoding siRNA resistant YFPSon (YFP-siR-Son) was also constructed in which the region of Son that
corresponds to the nucleotides targeted by Dharmacon siRNA oligo siGENOME
4 has been changed at seven nucleotide positions. YFP-Son Fl was digested
with BspEI and Mfe1 and this (1 Kb) fragment was subcloned into pEYFP-C1,
then site-directed mutagenesis was performed

using forward oligo 5’-

gccagttgtaacCatgAGCgtCgaAtaCcagatgaagtctg

and

-3’

reverse

oligo

5’-

cagacttcatctgGtaTtcGacGCTcatGgttacaactggc -3’ (the mutagenized nucleotides
are indicated in uppercase letters). Upon confirmation of mutagenesis of BspE1MfeI fragment by sequencing, this (1 Kb) fragment was subcloned back into YFPSon Fl to obtain YFP-siR-Son. Carboxyl terminal deletion mutants of YFP-Son-Fl
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were constructed by using convenient restriction sites already present in YFPsiR-Son that corresponded with sequence domain boundaries. To construct YFPSon-1-2008 (N-terminus through RS domain), a BspE1 + Sac I fragment (5.7 Kb)
of YFP-siR-Son was cloned into pEYFP-C1. To construct YFP-Son-1-1493 (N
terminus through repeats), a BspE1 + Bcl I fragment (4.4 Kb) of YFP-siR-Son
was subcloned into pEYFP-C1. The mutagenized YFP- BspE1-Mfe1 plasmid was
the deletion mutant YFP-Son 1-443 (amino terminus up to repeats).
Other cDNA constructs
YFP-Magoh was a gift from Dr.Catherine Tomasetto (Institute of Genetics
and Molecular and Cellular Biology, Strasbourg, France). mCherry-SF2 was a
generous gift from Dr. Prasanth K.V. (University of Illinois, Urbana-Champaign).
YFP-SF2/ASF was constructed by Dr. Paula. Bubulya. pTet-On, CFP-Lac I, YFPLacI were gifts from Dr. David Spector (Cold Spring Harbor Laboratory, NY)
Cell culture
HeLa cells and HeLa BTM cells were grown and maintained at 60-80%
confluency in 10 cm dishes using Dulbecco's Modified Eagle Medium (DMEM;
Hyclone,Thermoscientific,

Utah)

with

10%

fetal

bovine

serum

(FBS;

Hyclone,Thermoscientific, Utah) and 1% penicillin/streptomycin (50:100 units
penicillin, 50:100 μg streptomycin; Invitrogen). The cells were maintained at 37
ºC in the presence of 5% carbon dioxide. When cells were about 80% confluent
the cells were passaged by washing with 1X phosphate buffered saline (PBS;
137 mM NaCl; 2.7 mM KCl; 4.3 mM Na2HPO4; 1.47 mM KH2PO4, pH 7.4) two
times and adding 2ml of 0.25 % trypsin/EDTA (Hyclone, Thermoscientific, Utah)
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for 2-3 min at 37 ºC. DMEM was added to stop trypsinization and cells were
collected and centrifuged for 2 min at 1500 RPM in a 15 ml conical centrifuge.
The cells were resuspended in DMEM +10% FBS, counted and passaged as
needed. For immunofluorescence experiments, cells were seeded on to a 6-well
dish with sterile acid-washed coverslips (1.5 cm; Corning, NY). For siRNA knockdown experiments, cells were seeded in medium with no antibiotics prior to oligo
transfection. U2OS 2-6-3 cells (obtained from Dr. David Spector; CSHL, NY)
were grown and maintained in DMEM with 10% Tet-approved USA sourced FBS
(Cat# 631101; Clontech, CA). Transcription inhibition was performed when
needed by adding 50 µg/ml of alpha amanitin (Sigma; St.Louis, MO) to cell
culture medium DMEM for six hours prior to processing for immunofluorescence.
A YFP-Son stable cell line was generated by transfecting (see below) 10
µg of YFP-Son FL. After 24 hrs cells were washed in PBS and fresh medium was
added. After an additional 24 hrs, the cells were trypsinized for distribution to 10
plates. After the cells attached, 1 ml of medium containing 500 µg/ml of G418
(Gibco, CA) was added. After 2 weeks, fresh medium (DMEM with 50 µg/ml of
G418) was applied. Colonies were carefully scraped into individual wells of 24well dish, to screen for YFP-Son expression; replica dishes containing coverslips
were prepared and observed by microscopy.
Transfection
Transfection of HeLa cells with plasmid DNA was performed by using
calcium phosphate precipitation method. HeLa cells (5x106) were plated one day
before transfection in 10 cm dishes so the cells reached approximately 30-40%
24

confluency for transfection. In sterile conditions 10 µg of plasmid DNA was mixed
with 60 µl of 2M calcium chloride and 420 µl of sterile water in a 14 ml Falcon
tube. In another Falcon tube, 480 µl of 2X Hepes buffered saline (HBS) was
added. The DNA, calcium chloride and water was then added drop wise to the
2X HBS while slowly mixing using a vortex. The mixture was then added drop
wise to the cells. After 24 hrs the cells were washed thoroughly with 1X PBS
three to four times and DMEM was added. Forty eight hours post-transfection the
cells were harvested for experiments or processed further as needed.
For siRNA mediated knock down of Son, 3x104 HeLa cells were seeded
onto individual wells in a 24 well dish with or without sterile coverslips in DMEM
with 10% FBS (without antibiotics). After 24 hrs, these cells were transfected
using oligofectamine (Invitrogen, Carlsbad, CA) alone (mock) or with 60 pmol of
either non-targeting control siRNA duplex for luciferase (control) (catalog no. D001210-02; Dharmacon RNA Technologies) or Son siRNA duplex (si1 catalog #
J-012983-05 or si4 J-012983-08; Dharmacon RNA Technologies). The reaction
was scaled up 5 times for 1x 105 cells performed in a 6 well dish. For U2OS 2-6-3
cells, 1.5 x105 cells were seeded into a 6 well dish with or without coverslips and
the cells were transfected with 60 pmol of either the control siRNA duplex or with
Son siRNA duplex.
Transfection of U2OS 2-6-3 cells was performed by electroporation
according to published methods (Janicki et al.; 2004). Forty µg of salmon sperm
DNA (carrier DNA), 2 µg of YFP-Laci or CFP-LacI (labels the locus) was
transfected for each of the experiments. When we wanted the gene locus to be
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actively transcribing 2 µg of pTet-On was transfected with the above mentioned
plasmids. To visualize Son localization 2 µg of YFP-Son Fl or 2 µg of the deletion
constructs were used. To compare the localization of Son to a known SR protein
in relationship to the locus, 2 µg of mCherry SF2/ASF was transfected in some
experiments. The transcriptional activator pTet-on was omitted from cells treated
in parallel to ensure that Son-associated loci were transcriptionally inactive.
The required plasmid DNAs were added to a 4 mm electroporation cuvette
(BTX Harvard apparatus; MA). 1.5 x 106 U2OS-2-6-3 cells were then added to
cuvette and electroporated by using a Gene Pulser (BioRad, CA) at 170 V with a
capacitance of 950 µF and an infinite ohms resistance.
Immunoblotting
To prepare cell extracts for immunoblotting, cells were washed 2 times
with ice-cold PBS and removed from the plate by applying 1x PBS to the cells
and scraping using a rubber policeman. The cells were then placed in an
eppendorf tube and centrifuged for 5 minutes at 1200 rpm. Once the cells were
centrifuged they were resuspened in water (50 µl) and protein was extracted
using equal amount of 2X Laemmli buffer (4% SDS, 20% glycerol, 1.4M βmercaptoethanol, 0.125 M Tris HCl). Total protein concentration was obtained by
performing a Bradfdord assay (Pierce; IL). The protein samples were boiled for 5
minutes to denature the proteins. For the Bradford Assays, standards of 1 µg, 2
µg, 5 µg, 10 µg, and 20 µg of BSA were prepared in distilled water in a total
volume of 4µl. 2µl of cell extract was mixed with distilled water for a total volume
of 4µl. 496µl of water and 500µl of Coomassie Plus Protein Assay Reagent
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(Thermo Scientific) were then added for a final volume of 1mL. Samples were
loaded into 1mL cuvettes and absorbance was measured at λ495 on a Milton
Roy Spectronic 1001 Plus. A graph of OD versus µg protein was plotted with the
standard samples and a best fit line was applied. Once protein concentrations of
experimental samples were determined using absorbance readings and the
standard curve, 40 µg of each sample was used for SDS-poly-acrylamide gel
electrophoresis (SDS-PAGE). Equal amount of protein was loaded in each lane
of 7% polyacrylamide gels for immunoblots of SF2/ASF and U1-70K, and 15%
polyacrylamide for immunoblots of histone H3 phosphorylation at serine10
(H3S10P)

western

blots.

Electrophoresis

was

carried

out

in

protein

electrophoresis buffer (30 mM Tris HCL, 144 mM glycine, 0.01% SDS) at 150mV
until separation was achieved. Precision Plus protein ladder (BioRad) served as
the molecular mass marker. Proteins were then transferred onto nitrocellulose
membrane for 90 min at 200 mA in cold transfer buffer (Running Buffer
containing 20% methanol). Protein transfer was verified using a reversible
Ponceau staining (0.5% Ponceau S, 1% acetic acid). The membranes were
blocked using 5% non-fat dry milk in PBS containing 0.01% Tween-20 (PBST) for
30 min at room temperature. The membranes were probed with primary
antibodies diluted in blocking buffer targeting SF2/ASF (1:100, provided by A.
Krainer, CSHL, NY), and U1-70K (1:100; provided by S. Hoch, Agouron Institute,
La Jolla, CA) were used at a concentration of 1:100 each in 5% milk in PBST.
Primary antibodies against H3S10P (Abcam, Cambridge, United Kingdom) was
used at 1:500 and anti β-actin (Sigma-Aldrich) was used at 1:10,000 in 5% milk
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in PBST. Following 1 hr incubation at room temperature the membranes were
washed three times with PBST for 5 min each. HRP-conjugated secondary
antibodies,

anti-mouse

and

anti-rabbit

IgG

(Jackson

ImmunoResearch

Laboratories) were used at 1:50,000 in 5% milk in PBST for 1 hr at room
temperature for all immunoblots. After the secondary antibody incubation, the
membranes were washed 3 times for 5 min each with PBST and protein signal
was detected using enhanced chemiluminescence reagent (ECL reagent;Pierce,
IL) on a Fuji LAS 4000. The images were obtained digitally using Image Gauge
software (Fuji).
Immunofluoroscence
Cells grown on coverslips were washed briefly with 1X PBS and fixed
using 2% paraformaldehyde in 1X PBS for 15 min at room temperature.
Coverslips were then washed 3 times for 5 min each with 1X PBS. Cells were
permeablized by using 0.2% Triton X-100 with 0.5% normal goat serum in 1X
PBS at room temperature for five minutes. Following permeabilization, cells were
again washed three times for five minutes each with 0.5% normal goat serum in
1X PBS. The coverslips were then placed in a 15 cm dish serving as a humidified
chamber with cell side facing up. Primary antibody diluted in 0.5% normal goat
serum with 1X PBS was placed on the cells for 1 hr at room temperature. Rabbit
polyclonal antibodies developed (Covance; Denver, PA) against the C-terminal
peptide sequence SPNKKHAKATAATV of Son (WU13; 1:100), and against the
N- terminal peptide sequence CEESESKTKSH

of Son (WU14; 1:1000) and

WU15; 1: 15,000), monoclonal anti-SF2/ASF AK103 (1:2500) monoclonal anti-
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U1-70K 2.73 (1:100) and polyclonal anti-pinin A301-022A (1:1000; Bethyl
Laboratories, Montgomery, TX), human anti-nucleolar antibody (anti-fibrillarin,
1:20; Sigma-Aldrich, St. Louis, MO), and monoclonal anti-PML 5E10 (1:20;
provided by R. van Driel, University of Amsterdam, Amsterdam, The
Netherlands) were used. Cells were washed three times for 5 min with PBS
containing 0.5% normal goat serum and then incubated with fluorescent
conjugated secondary antibodies donkey anti-mouse and donkey anti-rabbit
proteins (1:500; Jackson ImmunoResearch Laboratories, West Grove, PA) for 1
hr at room temperature. Following secondary antibody incubation the cells were
washed with 1X PBS containing 0.5% normal goat serum 3 times for 5 min each.
The DNA was stained using 4', 6-diamidino-2-phenylindole (DAPI; 10 µg/ml
diluted 1: 1000 in 1X PBS) for 5 min and washed with 1X PBS for 5 min before
the slides were mounted using anti-fade mounting medium (p-phenylenediamine,
glycerol, p.H. 8.0-9.0) .
Peptide competition assay
Immunofluorescence was performed as described above, except that the
primary antibodies against Son (WU 13, WU14 and WU15) were incubated with
10 µM of their respective peptides, with control non-reactive peptide (N terminal
peptide for WU13 and C terminal peptide for WU14 and WU15), or with no
peptide on a rotating platform for 1 hr at room temperature. The antibody/peptide
mixture was centrifuged for 10 min at (16,000 g) to remove particles, and the
supernatant was used as a primary antibody to perform immunofluorescence.
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Bromo-UTP Incorporation
Cells were rinsed briefly in glycerol buffer (20 mM Tris HCl (pH 7.4), 5.0
mM MgCl2, 25% glycerol, 0.5 mM EGTA, and 0.5 mM PMSF). The cells were
pre-extracted using glycerol buffer supplemented with digitonin (20 μg/ml) for 5
min and incubated with pre-warmed transcription buffer (100 mM KCl, 50 mM
Tris HCl, pH 7.4, 5 mM MgCl2, 0.5 mM EGTA, 25% glycerol, 1.0 mM PMSF, 2.0
mM ATP, 0.5 mM GTP, 0.5 mM CTP, 0.2 mM bromo-UTP, 1.0 μg/ml RNAsin, 5.0
μg/ml digitonin) for 5 min at 37°C. Following the incorporation of bromo-UTP,
cells were washed briefly with 1X PBS then fixed in 2% formaldehyde in PBS for
15 min. Primary antibodies against Bromo-dUTP (Sigma; 1:100) and Son were
used to perform immunofluorescence as described above.
RNA FISH
RNA-fluorescence in-situ hybridization with oligo-dT probe was performed
after cells were processed for immunofluorescence localization of SF2/ASF.
During the immunofluorescence procedure, bovine serum albumin was used
instead of normal goat serum for all the blocking and antibody mixtures. Also
permeabilization was performed in presence of 250mM vanadyl–ribonucleoside
complex (VRC) to prevent RNase activity. Cells were again fixed using 2%
formaldehyde in 1X PBS for 15 min at room temperature and washed 2 times
with 2X SSC. An oligo-dT 50-mer probe (oligo-dT [50]) with the 3’ end labeled with
digoxigenin

(Genius

labeling

kit;

Boehringer

Mannheim

Biochemicals,

Indianapolis, IN) was used to probe for in situ hybridization of poly (A) + RNA. The
hybridization mixture had a total 20µl contained 80 ng oligo-dT
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[50],

2 x SSC, 1

mg/ml of tRNA, 10% dextran sulfate, and 25% formamide. The hybridization
mixture was placed onto a glass slide and coverslips were inverted cell side
down onto the mixture. The coverslip was sealed using rubber cement and the
slide was placed in a humidified chamber at 37 ºC overnight. The following
morning coverslips were floated from the slide in excess 2X SSC. Cells were
washed for 30 min at 37 ºC with 2X SSC containing 25% formamide followed by
a 30 min wash at room temperature with 2X SSC. Cells were then mounted in
anti-fade mounting medium.
To detect beta-tropomyosin minigene transcripts, RNA FISH was
performed prior to performing immunofluorescence because antibodies against
Son could not survive the FISH protocol. The hybridization mixture had a total of
20

ng

of

5`

texas

red

labeled

30-mer

(5`-TXRD-

CTCTCAGCCACCTCGGCTCTCTCTTCAGAG 3`) probe targeting exon 5 of the
minigene and/or a 24-mer probe which was Cy-5 labeled at the 5` end targeting
exon

junction

of

exon

5

and

exon

7

(5`

CY5-

TCCCCACATTTACTCTCAGCCACC 3`). After performing the FISH as described
above, the cells were washed with 1x PBS for 5 min and fixed using 2%
formaldehyde for 15 min. The cells were then washed three times with 1X PBS
for 5 min each and blocked in 0.5% RNase-free BSA in 1X PBS. The
immunofluorescence was performed as described above except the antibodies
were prepared in 0.5% RNase-free BSA in 1X PBS. The cells were then mounted
by using N-propyl gallate mounting mounting medium (n-propyl gallate 0.05g, 1M
Tris-HCl (pH 8.0) 1ml and 9mls of glycerol) because the anti-fade mounting
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medium has a tendency to have bleed-through signal from Texas Red in Cy-5
channel when performing microscopy.
Microscopy
Images were collected as z stacks spanning the entire nucleus using a
60X objective (1.4 numerical aperture; Olympus, Tokyo, Japan) on a DeltaVision
RT microscope (Appplied Precision). The raw stack images were then displayed
as volume projections. In case of U2OS cells, and the beta-tropomyosin cells, the
raw images were deconvolved and displayed as volume projections.
Time-lapse microscopy was performed by plating 3x105 HeLa cells stably
expressing YFP-SF2/ASF onto 60-mm coverslips. After 24 hrs the cells were
subjected to siRNA treatment using Son siGENOME 4. Thirteen hours posttransfection, the cells were placed on to a live imaging chamber (Bioptechs,
Butler, PA). The chamber was perfused with L-15 medium (without phenol red)
containing 20% fetal bovine serum, and placed into a 37 °C environmental
chamber on the stage of a DeltaVision RT imaging system. Z-stack images were
acquired through the entire nucleus every 5 min for 6 hrs. The raw images were
then displayed as a volume projection for each time point and projections were
displayed as a video file showing nuclear speckle dynamics after Son siRNA
transfection.

Vi-cell and Flow Cytometry
To perform counts of viable HeLa cells, (1X105) were seeded in 4 wells of
a six well dish in 8 replicates for a time course analysis. Each 6 well dish was
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transfected in parallel with mock, control siRNA duplex, or siRNA duplexes
targeting Son (Dharmacon siGENOME1 and siGENOME 4). Cells were extracted
over a time course, beginning at the time of transfection, and every 24 hrs for 72
hrs. Medium was collected and centrifuged to pellet floating cells, and attached
cells were washed with 1X PBS followed by trypsinization at 37 ºC for 2 min.
Trypsinization of cells was stopped by addition of DMEM with 10% fetal bovine
serum, penicillin and streptomycin. Cells were centrifuged for 2 min at 1500 RPM
and supernatant was discarded. The cells were resuspended using 1ml of DMEM
and then transferred to a Vi-cell chamber.
At each time point, cells were also extracted in a pellet as described
above to perform cell cycle analysis using flow cytometery. Cells were pelleted
by centrifugation, washed with 1X PBS and centrifuged again at 4 ºC for 2 min at
1,500 RPM. The cells were resuspended in 200 µl of ice cold 1X PBS and then 1
ml of ice-cold ethanol was added by slow vortexing to fix the cells. The cells were
then placed overnight at -20 º C. The next day the cells were centrifuged at 1,500
RPM, supernatant was discarded and cells were resuspended in 1 ml of 1X PBS
with 1 µg of RNAse. The cells were incubated at 37 ºC for 30 min. After RNase
treatment, cells were centrifuged and the supernatant was discarded. The cells
were resuspended with 1X PBS and 1 µl of propidium iodide (10µg/µl). The DNA
content of the cells was analyzed by flow cytometry (BD Sciences). While
performing flow cytometery asynchronized HeLa cells were used to set the
gating. The same gates were used to collect the experimental data.
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RNA extraction
RNA extraction was performed by using Qiagen RNAeasy mini prep kit.
Cells were trypsinized and collected by centrifugation for 2 min at 1,500 RPM.
Cells were resuspended in 1X PBS and centrifuged again to pellet to wash out
medium. Cells pellet was disrupted by using buffer RLT (350 µl; buffer
composition is proprietary) and by passing the cells through a 20 gauge needle
at least 5 times. Equal amount of 70% ethanol was then added to the cell
suspension and this mix was then applied to an RNA spin column in a 2 ml
collection tube. The tube was centrifuged for 15 seconds at 4 ºC and the flowthrough was discarded. 700 µl of buffer RW1 (proprietary buffer) was then added
to the spin column. The tube was centrifuged for 15 s at 4º C and the flowthough was discarded again. The column was then washed twice using 500 µl of
buffer RPE (proprietary buffer) with ethanol. The collection tube was discarded
after the two washes and the column was placed in a new collection tube. The
column was centrifuged for 1 min full speed to remove residual buffer RPE. The
spin columns were placed in an Eppendorf collection tube and RNA was eluted
by adding 30 µl of RNase-free water. This step was used twice to increase the
amount of RNA obtained. The RNA was stored at -80 ºC.
DNase treatment of RNA for RT-PCR
1 to 10 µg of total RNA was used as the starting material for DNase
treatment with Turbo DNA-Free kit (Ambion) to remove contaminating DNA from
RNA preparations, and to subsequently remove the DNase and divalent cations
from the DNase-treated RNA samples. The proprietary TURBO DNase is an
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engineered version of wild type DNase I with higher affinity for DNA than
conventional DNase I. Turbo DNase, activation buffer and RNA were mixed in a
50 µl reaction and were incubated for 30 min at 37 ºC. DNase inactivation
reagent was then added to the mixture. Following 5 min room temperature
incubation of this mix with ocassional mixing, the tubes were centrifuged at
(16,000 X g) for 1.5 min in a table top centrifuge. The supernatant (DNA-free
RNA) was the transferred to a new Eppendorf tube and the concentration was
measured by using a Nanodrop spectrophotometer (Thermoscientific).
Semi-quantitative and Quantitative RT-PCR
Semi-quantitative RT-PCR was performed with SuperScript One-Step RTPCR System (Invitrogen) using 100 ng of total DNA-free RNA as a template to
compare level of Son transcripts after Son depletion. The linear range of
amplification was determined by performing RT-PCR and stopping the reaction at
15,

20,

25,

30,

35

and

40

cycles

of

PCR

using

primers

5`

CAGAACTACGATATAAGCC 3` and 5` GATACAACTGACAGTTCTGC 3` for
Son mRNA levels and 5` ATGGGGAAGGTGAAGGTCGGAG 3` and

5`

CATGTAGTTGAGGTCAATGAAGG 3` for GAPDH mRNA levels. To determine
the levels of amplification for exogenous Son expression, primers targeting YFP
5` GGAGGAGAAGCAGCAGATC 3` and 5` GTGGTATGGCTGATTATG 3` were
used. The linear range of amplification of 32 cycles was used to perform semiquantitative RT-PCR. The products of semi-quantitative RT-PCR were then run
on 2 % agarose gels to separate and visualize the products.
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Quantitative analysis of Son mRNA depletion was performed with BR-1
step Sybr green QRT-PCR kit (Quanta) using 100 ng of total RNA and primers 5`
GTACCCTGAGCCAAGCACAT 3` and 5` GGCTGCTCTGGCAATCTTAG 3`.
GAPDH

primers

5`

ATGTTCGTCATGGGTGTGAA

3`

and

5`

GGTGCTAAGCAGTTGGTGGT 3` were used as an internal control for all QRTPCR reactions. For quantitative analysis of beta-tropomyosin transcript, targeting
the region spanning exon 5 intron 5 (5` AGCTGGTGATCCTGGAAGG 3` and
5`ACCCGGGTATCCCTACCTC

3`),

intron

5

exon

6

(5`

AGGCCACAGGAATAGGCTTT 3` and 5` CCATGGTTCGAAGCTCCTC 3`),
exon

6

intron

6

(5`

AGGTGCCATTGCCTAGAAAG

CAGGCTCTCAAGTCGCTGAT
3`),

exon

5

exon

3`

and

5`

6

(

5`

CTGAAGAGAGAGCCGAGGTG 3` and 5` GACTTGAGAGCCTGGTCCAT 3`),
exon

5

and

exon

7

(5`

CTGAAGAGAGAGCCGAGGTG

3`

and

5`

CCTCCTCTAGGTCCCCACAT 3`), exon 5 ( 5` CCAGGAAGCTGGTGATCCT 3`
and

5`

AGCCACCTCGGCTCTCTC

3`)

and

intron

5

(

5`

TGGAACGAATGGGATGATAGA 3` and 5` AGCCTATTCCTGTGGCCTCT 3`)
were used to analyze transcription level changes occurring after Son depletion of
each of these regions specified. The products were analysed by running on a
12% polyacrylamide gel made using 5X TBE (1.1M Tris; 900mM Borate; 25mM
EDTA; pH 8.3) and run at 120V for 60 min in 1X TBE. The gels were stained on
shaking platform by adding 2 µl of 10mg/ml ethidium bromide to 300 ml of buffer
1X TBE for 5 min before exposing to ultraviolet light.
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Identification of genome wide transcription and splicing targets of Son
Five replicates of the Human Exon Array 1.0 ST were performed on RNA
samples from Son depleted and control oligo treated cells. RNA samples were
subjected to DNase treatment as described above. Son depletion was confirmed
by QRT-PCR using the primers against Son mentioned in section above. GAPDH
primers were used as an internal control for the reaction. The PCR products were
verified by 12% native polyacrylamide gel electrophoresis. RNA quality was
determined by microfluidic analysis, using the Agilent 2100 Bioanalyzer with an
RNA LabChip Kit (Agilent; CA). The RNA integrity number (RIN) of 9.1 was
obtained to ascertain that the RNA was free of contaminants such as protein,
phenol, ethanol and salts.
Whole Transcript (WT) expression array kit (Ambion) was used to
generate biotinylated sense strand DNA targets from the isolated RNA. The WT
expression kit uses a reverse transcription priming method that specifically
primes non-ribosomal RNA from the samples, including both poly (A) and nonpoly (A) mRNA. Primers that avoid rRNA binding are designed by using a
proprietary-oligonucleotide matching algorithm. These primer sequences provide
complete and unbiased coverage of the transcriptome while significantly reducing
the priming of rRNA. 100 ng of total RNA was used from each sample and first
strand synthesis was performed by using first strand enzyme mix (composition
proprietary) and buffer (composition proprietary) in the PCR tubes provided
(Ambion; WT expression kit). Samples were incubated for 1 hr at 25 °C, then for
1 hr at 42 °C, then for at least 2 min at 4 °C in a thermal cycler using the first-
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strand cDNA synthesis protocol (Ambion; WT expression kit). This cDNA was
stored overnight at -80 ºC. The next day single stranded cDNA was converted to
double stranded DNA. The reaction used RNase H and DNA polymerase.
Second strand enzyme mix and buffer was added to the first strand cDNA and
the tubes were incubated for 1 hr at 16 °C, then for 10 min at 65 °C, then for at
least 2 min at 4 °C in a thermal cycler.
Using the double stranded cDNA library generated as a template, a cRNA
library was made by using T7 RNA polymerase in an in-vitro transcription
reaction. The in-vitro transcription enzyme mix and buffers were added at room
temperature to the double stranded cDNA library and it was incubated for 16 hrs
at 40 ºC and then overnight at 4 ºC. The cRNA was then purified by adding 10 µl
of nucleotide binding beads and 50 µl of nucleotide binding buffer concentrate to
each reaction. After mixing the beads and buffer 60 µl of isopropyl alcohol was
added to each reaction and they were incubated on a gently rocking shaker for 2
min. The beads are captured by placing on a magnetic stand and by aspirating
the clear supernatant carefully. The beads were then washed twice with nucleic
acid wash solution (composition proprietary) and each time the beads were
collected at the bottom by using a magnetic stand. The cRNA was then eluted by
using the pre-heated (55 ºC) elution buffer (composition proprietary). The cRNA
was then placed on ice briefly and then stored at -80 ºC.
The cRNA was quantified by using the nano-drop and by cRNA size
distribution using an Agilent 2100 Bioanalyzer, and an RNA 6000 Nano Kit (PN
5067-1511). 10 µg of cRNA was used to synthesize the second cycle cDNA
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(synthesis of sense strand cDNA by reverse transcription) with the help of
random primers. The cRNA, and primers were incubated in a thermocycler for 5
min at 70 ºC, then 5 min 25 ºC and finally for 2 min at 4 ºC followed by addition of
the second cycle enzyme and buffer mix. This mixture was then incubated using
a thermocycler for 10 min at 45 ºC, then 90 min at 42 ºC, followed by 10 min at
70 ºC and 2 min at 4 ºC. Once these steps are completed the sample received 2
µl of RNAse H to digest the left over RNA and was incubated for 45 min at 37 ºC,
then 5 min at 95 ºC followed by 2 min at 4 ºC in a thermocycler.
To purify the cDNA mix, 10µl of nucleotide binding beads and 50 µl of
nucleotide binding buffer concentrate were added to each reaction. After mixing
the beads and buffer 120 µl of ethanol was added to each reaction and they were
incubated on a gently rocking shaker for 2 min. The beads were captured by
placing on a magnetic stand and by aspirating the clear supernatant carefully.
The beads were then washed twice with nucleic acid wash solution (composition
proprietary) and each time the beads were collected at the bottom by using a
magnetic shaker. The cDNA was then eluted by using the pre-heated (55 ºC)
elution buffer (composition proprietary). The cDNA was placed on ice briefly and
then stored at -80 ºC. The quality of DNA was analysed by using the nano-drop
spectrophotometer (Thermo Scientific). This purified sense strand cDNA has an
incorporation of dUTP which is ready for fragmentation and labeling using the
Affymetrix GeneChip WT terminal labeling kit as described further.
The sense strand cDNA obtained as described above was subjected to a
combination of uracil DNA glycosylase (UDG) and apurinic/apyrimidinic
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endonuclease 1 (APE 1) that specifically recognizes the unnatural dUTP
residues and breaks the DNA strand. 5.5 µg of sense cDNA was used and 16.8
µl of fragmentation mix was added and incubated at 37 ºC for 60 min followed by
93 ºC for 2 min and 4 ºC for 2 min in a thermocycler. 45 µl of sample was then
transferred to 0.2 ml strip tube and the rest was analysed on the bioanalyser to
confirm that the fragments obtained were 40-70 nt in length. The fragmented
cDNA was stored at -20 ºC overnight. A master mix using the 5X
deoxynucleotidyl transferase (TdT) buffer, TdT and DNA Labeling reagent was
prepared and 15 μl was added to 0.2 ml strip tubes containing the 45 μL of
fragmented single-stranded DNA. TdT is an Affymetrix® proprietary DNA labeling
reagent that is covalently linked to biotin. After adding the labeling mix the tubes
were incubated for 60 min at 37 ºC, followed by 10 min at 70 ºC and then 2 min
at 4 ºC. A hybridization cocktail was prepared by adding the fragmented and
labeled DNA, DMSO, control oligonucleotides, 20X eukaryotic hybridization
controls, water and 2X hybridization mix (composition proprietary). This cocktail
was heated on a heat block for 5 min at 99 ºC, cooled to 45 ºC for 5 min and
centrifuged at full speed for one minute. This cocktail was then injected through
the septa in the Affymetrix GeneChip ST Array. The array was then placed in a
45 ºC hybridization oven, at 60 RPM for 17 hrs.
Once hybridized on the chip each sample goes through an automated
washing, staining and scanning on the fluidics station using Affimetrix protocol
F5450_0007. The scan generates .cel files which are further analysed by using

softwares described below.
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Analysis of exon array data
In order to identify genes with differential gene expression or alternative
splicing between the groups Son siRNA4 and control we studied 10
hybridizations on the Human Exon 1.0 ST array using mixed model analysis of
variance. The analysis was run on December 10, 2009 by CGR Computer with
XRAY (version 3.998) software, the Excel add-in from Biotique Systems Inc.
(Burke, 2007). The 10 input CEL files were analyzed with the Affymetrix
HumanExon1.0 ST array to identify genes that were significantly differentially
expressed or displayed (Gardina, et al 2006; Huang, et al 2007; Clark et al
2007) significant differential alternative splicing between the groups of interest.
The input files were assigned to 2 groups, control and Son siRNA, and analyzed
for differential gene expression and alternative splicing. The 2 groups were
analysed by Alt-Analyse, cross-platform application that allows us to process
microarray data and assess genome wide change in transcript levels as well as
alternative splicing events. Alt-Analyse uses core exons to detect the changes in
transcription by using the "Detection Above Background" (DABG), and follows
the splicing index algorithm (the log ratio of the exon intensities between
samples) and the MIDAS algorithm (uses the ANOVA model on the splicing
index) to predict alternative splicing. A Benjamini-Hochberg correction is applied
in this software and helps in eliminating false positives that are usually obtained
during the exon array analysis.
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Primer Design
Once a gene was identified to show splicing site change after Son
depletion, the Affimetrix probe sequence was obtained by using the probe
number from the Affimetrix website. The gene sequence was obtained by going
to UCSC website from the probe page selecting the 5`UTR, 3` UTR and the
genetic sequence of exons in capital letters and introns in lower case. The
sequence was copied and pasted onto Serial cloner software. The probe
targeting sequence was copied and was searched on both strands of the
sequence in Serial cloner. Once identified, the probes before and after were
copied individually and found in Serial cloner to identify what portion of exon or
intron was upregulated or downregulated corresponding to the event called by
XRAY or Alt-analyse. The intended target was then pasted in Primer-3 online
software. Skipped exons were marked as the included sequence and primers of
Tm approximately 60 ºC were selected by the software Primer-3. The primers
obtained were then copied in Serial cloner to run a virtual PCR and expected
sizes were calculated for exon-skipped, unspliced and normal spliced products.
The primers specificity was then verified by using short sequence blast at the
NCBI website, prior to use of qPCR reactions.
Core exon primer sets 5` GCTGATGGCTACATCGACCT 3` and 5`
CCGTCGTTGTTCTTGTCTCC 3` were used to identify cardiac troponin levels
and

primer

sets

5`

CTGTCCAGCGTATCTCAGCA

3`

and

5`

GAGTGAGAAATTCGGGCTCA 3` were used to identify cyclin dependent kinase
mRNA levels. To validate alternative splicing of endogenous genes after Son
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depletion

primer

set

5`

AGGTCAGGACATGGCTGATT

3`

and

5`

CCGTATTCTGGGGCTTAGTG 3` were used for histone deacytalyse 6 (HDAC6),
primers

sets

5`

AGGCGGTGACAGAGTGGAG

3`

and

5`

GATCTTTGACTGCCCGGTAAAT 3` were used for Set domain 8 (SetD8) also
known

as

histone

lysine

methyl

transferase

8

and

primer

sets

5`

GCTACCACACCCTGGAAGAC 3` and 5` GGGTGGACTTGAAGATGAGC 3`
were used for adenosine deaminase (ADA).
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CHAPTER 3
Son is important to maintain nuclear speckle integrity
YFP-Son localize to nuclear speckles
At the outset of this project, anti-Son antibodies and full-length cDNA
constructs were not available; we therefore generated these reagents. Rabbit
polyclonal antibodies were raised with the help of Covance laboratories against
the peptide (EESESKTKSHDDGNI) at the C terminus of Son (WU13) and
against peptide (SPNKKHAKATAATV) at the N terminus (WU14 and WU15). In
addition the full-length Son cDNA was assembled from truncated cDNAs
obtained from Kazusa DNA Research Institute; Japan (see methods). HeLa cells
were transfected with YFP-Son in order to confirm localization of Son in nuclear
speckles. YFP-Son (Figure 3, panel A) colocalized with SF2/ASF, an essential
splicing factor that typically localizes to nuclear speckles (Figure 3, panel B).
Specific Son antibodies show endogenous Son localizes to nuclear
speckles
To validate that the antibodies raised by Covance are specific for Son, we
performed dual label immunofluorescence with antibodies targeting SF2/ASF and
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Figure 3: Full length YFP-Son localizes to nuclear speckles
YFP-Son was transfected, by using the calcium phosphate method, in HeLa cells
plated on coverslips.
(A) Panel shows YFP-Son localization.
(B) Panel shows immunofluorescence performed on the same cells 48 hrs posttransfection by using antibody targeting a known speckle protein SF2/ASF
(1:2500) and secondary Texas-red conjugated donkey anti mouse (1:500).
(C) Panel shows merge of YFP-Son and SF2/ASF.
(D) DNA was stained using DAPI.
The arrows show co-localization of YFP-Son and SF2/ASF in nuclear speckles.
Bar = 5 µm.
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the pre-immune bleeds or the affinity purified antibodies WU13, WU14 and
WU15. The pre-immune bleeds from rabbits WU13, WU14 and WU15 showed no
specific immunolabeling (Figure 4, panels A, I and Q) as compared to affinity
purified antibodies targeted towards Son (Figure 4, panels E, M and U) that
showed colocalization in nuclear speckles with SF2/ASF (Figure 4, panels G, O
and W) suggesting that Son is a nuclear speckle component. To verify that the
purified antibodies are specific for the peptide they are raised against, a peptide
competition assay was performed by pre-incubating WU13 antibody with the Cterminal peptide antigen, or with the non specific N-terminal peptide or with no
peptide.

These

incubated

antibodies

were

used

in

a

dual

label

immunofluorescence experiment with antibodies targeting SF2/ASF. Results
showed that the specific immunolabeling of WU13 that targets the C-terminus of
Son seen with no peptide (Figure 5, panel A) or with the control N-terminal
peptide (Figure 5, panel E) was totally abolished when incubated with the Cterminal peptide used to raise the WU13 antibody (Figure 5, panel I). Similar
experiments were performed with WU14 and WU15 antibodies (Figure 6 and
Figure 7 respectively). Specific immunolabeling of WU14 and WU15 was seen
with no peptide (Figure 6, panel A and Figure 7, panel A, respectively) or with the
control C-terminal peptide (Figure 6, panel E and Figure 7, panel E) was totally
abolished when incubated with the specific N-terminal peptide (Figure 6, panel I
and Figure 7, panel I) used to raise the WU14 and WU15 antibodies. Cells
incubated with control peptide or no peptide retained specific labeling of Son in
nuclear speckles where it colocalized with SF2/ASF (Figure 6, panel K and
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Figure 7, panel K). We further checked colocalization of Son in nuclear speckles
using antibodies targeting another bonafide nuclear speckle component, SC35
(Figure 8, panel, B), and WU14 anti-Son antibody (Figure 8, panel A). Results
showed that Son colocalized with SC35 in nuclear speckles (Figure 8, panel C).
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Figure 4: Endogenous Son localizes to nuclear speckles
Dual labeled immunofluorescence performed on HeLa cells after fixation with 2%
paraformaldehyde and permeabilization with 0.2% Triton-X 100.
(A) Pre-immune bleeds from animal used to generate WU13 antibody (1:100)
and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(E) Localization of endogenous Son by using purified primary antibody WU13
(1:100) and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(I) Pre-immune bleeds from animal used to generate WU14 antibody (1:1000)
and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(M) Localization of endogenous Son by using purified primary antibody WU14
(1:1000) and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(Q) Pre-immune bleeds from animal used to generate WU15 antibody (1:15,000)
and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(U) Localization of endogenous Son by using purified primary antibody WU15
(1:15,000) and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(B), (F), (J), (N), (R) and (V) are panels depicting localization of SF2/ASF in
nuclear speckles using primary antibody anti-mouse SF2/ASF (1:2500) and
secondary antibody Texas-red conjugated donkey anti mouse (1:500).
(C), (G), (K), (O), (S), and (W) are merge panels showing co-localization of
SF2/ASF and the pre-immune bleeds and the purified antibodies of Son.
(D), (H), (L), (P), (T), and (X) are panels showing DNA stained using DAPI.
The arrows show co-localization of endogenous Son and SF2/ASF in nuclear
speckles. Bar = 5 µm.
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Figure 5: WU13 antibody is specific to Son.
Dual labeled immunofluorescence performed on HeLa cells after 2% fixation with
paraformaldehyde and permeabilization with 0.2% Triton-X 100.
(A) Immunolabeling of endogenous Son by using purified primary antibody WU13
(1:100) and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(E) Immunolabeling of endogenous Son by using purified primary antibody WU13
(1:100) incubated with amino terminal peptide (10 µM) used to generate
antibodies WU14 and WU15. FITC conjugated donkey anti-rabbit antibody
(1:500) was used as a secondary.
(I) Immunolabeling using purified primary antibody WU13 (1:100) incubated with
carboxy- terminal peptide (10 µM) used to generate antibody WU13
(B), (F) and (J) show immunolabeling of SF2/ASF in nuclear speckles using
primary antibody anti-mouse SF2/ASF (1:2500) and secondary antibody Texasred conjugated donkey anti mouse (1:500).
(C), (G) and (K) are merge panels showing co-localization with SF2/ASF.
(D), (H) and (L) are panels showing DNA stained using DAPI.
The arrows show co-localization of endogenous Son and SF2/ASF in nuclear
speckles. Bar = 5 µm.
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Figure 6: WU14 antibody is specific to Son.
Dual labeled immunofluorescence performed on HeLa cells after 2% fixation with
paraformaldehyde and permeabilization with 0.2% Triton-X 100.
(A) Immunolabeling of endogenous Son by using purified primary antibody WU14
(1:1000) and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(E) Immunolabeling of endogenous Son by using purified primary antibody WU14
(1:1000) incubated with carboxy-terminal peptide (10 µM) used to generate
antibody WU13. FITC conjugated donkey anti-rabbit antibody (1:500) was used
as a secondary.
(I) Immunolabeling using purified primary antibody WU14 (1:1000) incubated with
amino terminal peptide (10 µM) used to generate antibodies WU14 and WU15.
(B), (F) and (J) show immunolabeling of SF2/ASF in nuclear speckles using
primary antibody anti-mouse SF2/ASF (1:2500) and secondary antibody Texasred conjugated donkey anti mouse (1:500).
(C), (G) and (K) are merge panels showing co-localization with SF2/ASF.
(D), (H) and (L) are panels showing DNA stained using DAPI.
The arrows show co-localization of endogenous Son and SF2/ASF in nuclear
speckles. Bar = 5 µm.
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Figure 7: WU15 antibody is specific to Son.
Dual labeled immunofluorescence performed on HeLa cells after 2% fixation with
paraformaldehyde and permeabilization with 0.2% Triton-X 100.
(A) Immunolabeling of endogenous Son by using purified primary antibody WU15
(1:15,000) and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(E) Immunolabeling of endogenous Son by using purified primary antibody WU15
(1:15,000) incubated with carboxy-terminal peptide (10 µM) used to generate
antibody WU13. FITC conjugated donkey anti-rabbit antibody (1:500) was used
as a secondary.
(I) Immunolabeling using purified primary antibody WU15 (1:15,000) incubated
with amino terminal peptide (10 µM) used to generate antibodies WU14 and
WU15.
(B), (F) and (J) show immunolabeling of SF2/ASF in nuclear speckles using
primary antibody anti-mouse SF2/ASF (1:2500) and secondary antibody Texasred conjugated donkey anti mouse (1:500).
(C), (G) and (K) are merge panels showing co-localization with SF2/ASF.
(D), (H) and (L) are panels showing DNA stained using DAPI.
The arrows show co-localization of endogenous Son and SF2/ASF in nuclear
speckles. Bar = 5 µm.
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Figure 8: Endogenous Son colocalizes to SC35 in nuclear speckles
Dual labeled immunofluorescence performed on HeLa cells after fixation with 2%
paraformaldehyde and permeabilization with 0.2% Triton-X 100.
(A) Immunolabeling of endogenous Son by using purified primary antibody WU14
(1:1000) and Texas-red conjugated donkey anti-rabbit secondary antibody
(1:500).
(B) Immunofluorescence performed on the same cells by using antibody
targeting a known speckle protein SC35 (1:100) and secondary FITC conjugated
donkey anti mouse (1:500).
(C) Merge panel of Son and SC325.
(D) The DNA was stained using DAPI.
The arrows show co-localization of Son and SC35 in nuclear speckles. Bar = 5
µm.
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Son does not localize to PML bodies, nucleoli or Cajal bodies.
We also wanted to rule out localization of Son in other nuclear
compartments that are enriched in RNA processing factors.

Dual label

immunofluorescence was performed with WU14 anti-Son antibody (Figure 9,
panel A) and 5E10 anti-PML that labels PML bodies (Figure 9, panel B). Son
does not localize in PML bodies (Figure 9, panel C). To further characterize the
nuclear localization of Son we performed dual label immunofluorescence
experiments on HeLa cells with antibodies against fibrillarin (Figure 9, panel F)
and Son (Figure 9, panel E). The data shows that Son does not colocalize with
fibrillarin in the nucleolus or in Cajal bodies (Figure 9, panel G).
Son depletion alters localization of nuclear speckle proteins
If Son is important for nuclear speckle organization, then the morphology
of nuclear speckles should change when Son is depleted. siRNA-mediated
depletion of Son was used to study the effect of Son knock down on nuclear
speckle integrity. Cells were treated separately with two siRNA oligos targeting
different regions of Son mRNA (Dharmacon). Semi-quantitative RT-PCR was
used to compare Son mRNA levels in these cells (Figure 10B, top panel, lanes 4
and 8) to that in mock (Figure 10B, top panel, lanes 2 and 6) and control oligo
transfected cells (Figure 10B, top panel, lanes 3 and 7). Equal loading of RNA
was confirmed by levels of GAPDH transcripts (Figure 10B, bottom panel, all
lanes). Neither Son nor GAPDH transcripts were detected when reverse
transcriptase was omitted from the reaction (Figure 10B, top and bottom panels,
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Figure 9: Son does not localize to PML bodies, nucleoli or Cajal bodies.
Dual labeled immunofluorescence performed on HeLa cells after 2% fixation with
paraformaldehyde and permeabilization with 0.2% Triton-X 100.
(A) and (E) Panels are immunolabeled with Son using affinity purified WU14
(1:1000) and Texas-red conjugated donkey anti-rabbit secondary antibody
(1:500).
(B) Panel shows labeling of the same cell in panel (A) with PML body protein
5E10 (1:20) and FITC conjugated donkey anti-mouse secondary antibody
(1:500).
(F) Panel shows labeling of the same cell in panel (E) with anti-human Fibrillarin
(1:20) and FITC conjugated donkey anti-human secondary antibody (1:500).
(C) Merge image of PML bodies and Son.
(G) Merge image of Fibrillarin and Son.
(D) and (H) Panels showing DNA stained using DAPI.
Arrows show labeling of PML in panels (C) and (D). Arrows in (F) and (G) show
labeling of the nucleolus and arrowheads mark the Cajal bodies. Bar = 5 µm.
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lanes 1 and 5). Subsequent loss in protein levels post-siRNA transfection was
verified by western blotting using antibody WU15 for siRNA 4 (Sharma et al.,
2010) and immunofluorescence using WU14 antibody against Son showed a
decrease in Son immunolabeling (Figure 10A, panels I and M). Interestingly,
nuclear speckle morphology changed from an irregular shape to a doughnut
shaped phenotype in Son depleted cells as observed using two different Son
siRNAs (Figure 10A, arrows panels J and N), while the nuclear speckles in cells
treated with control siRNA oligo targeting luciferase (Figure 10A, arrows panels E
and F), or with the vehicle (Oligofectamine) (Figure 10A, arrows panels A and B)
showed normal speckle morphology. Son depletion did not cause morphological
change in Cajal bodies when observed by U1-70K snRNP antibody (Figure 10A,
arrowhead panel N), suggesting that only the nuclear speckle pool of splicing
factors but not those in Cajal bodies were being reorganized after Son depletion.
The same phenotype was observed in Son-depleted cells labeled using
antibodies targeting nuclear speckle proteins such as SF2/ASF (Figure 11A,
arrows panels J and N) and pinin (Figure 12, arrow panel J). A Western blot
analysis of Son depleted cells treated in parallel showed that there was no
change in the protein expression levels of U1-70K and SF2/ASF in Son depleted
cells (Figure 13, top panel, lanes 3 and 4) when compared to mock (Figure 13,
top panel, lane 1) and control (Figure 13, top panel, lane 2). Equal loading was
verified by beta-actin immunoblot (Figure 13, bottom panel, all lanes). SF2/ASF
re-organized to a doughnut shaped phenotype after Son depletion by human
siGENOME1 in mouse NIH3T3 cells which are non-transformed cells (Figure 11
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B, panel W). No specific labeling for Son was observed in Son depleted cells
(Figure 11B, panel U). This was possible because the sequence targeted by
siGENOME1 is conserved in mouse Son mRNA. The control siGENOME
transfected cells did not show a change in speckle morphology (Figure 11B,
panel S). The change in phenotype in mouse NIH3T3 cells suggest the doughnut
shaped phenotype observed after Son depletion is not specific to HeLa cells.
The change in speckle morphology to a doughnut shaped phenotype after
Son depletion was also confirmed with HeLa cells stably expressing SC35-YFP
(Figure 14, arrows panels J and N) , as well as with cells transiently expressing
the exon junction complex (EJC) protein YFP-Magoh (Figure 15, arrow panel J).
The mock (Figure 14 and Figure 15, arrows panels A and B) and control
transfected cells (Figure 14 and Figure 15, arrows panels E and F) in both YFPMagoh as well as SC35-YFP show normal speckle localization. The
reorganization of YFP-Magoh into doughnut shaped phenotype following Son
depletion suggests that the reorganization is not limited to proteins involved in
splice site recognition but also affects other pre-mRNA processing factors.
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Figure 10: siRNA mediated Son depletion alters localization of U1-70K
snRNP protein.

A. HeLa cells grown on coverslips were transfected with Mock (vehicle
oligofectamine) (A-D), Control oligonucleotides targeting luciferase (60 pmoles)
(E-H), Son siGenome 1 oligonucleotides (60 pmoles) (I-L) and Son siGenome 4
(60 pmoles) (M-P). 24 hrs post transfection cells were processed for dual labeled
immunofluorescence against Son and U1-70K snRNP protein.
(A), (E), (I), and (M): Panels show immunolabeling using affinity purified WU14
(1:1000) and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(B), (F), (J) and (N): Panels show immunolabeling of U1-70K snRNP protein
using primary antibody anti-mouse U1-70K snRNP protein (1:100) and
secondary antibody Texas-red conjugated donkey anti mouse (1:500).
(C), (G), (K) and (O) are merge panels showing immunolabeling of Son and U170K snRNP protein.
(D), (H), (L) and (P) Panels where DNA was stained with DAPI. Bar = 5 µm.

B. A duplicate set of the siRNA experiment was performed and RNA was
extracted and semi-quantitative PCR was performed to evaluate the transcript
levels of Son and GAPDH. Son mRNA was depleted after Son siRNA treatment
by both siRNA oligos targeting Son (lanes 4 and 8) as compared to the mock
(lanes 2 and 6) and control oligo transfected cells (lane 3 and 7). The levels of
GAPDH did not change in any of the treatments. None of the transcripts were
observed when reverse transcriptase was omitted from the reaction (lanes 1 and
5).
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Figure 11: siRNA mediated Son depletion alters localization of SF2/ASF.
A. HeLa cells grown on coverslips were transfected with Mock (vehicle
oligofectamine) (A-D), Control oligonucleotides targeting luciferase (60 pmoles)
(E-H), Son siGenome 1 oligonucleotides (60 pmoles) (I-L) and Son siGenome 4
(60 pmoles) (M-P). 24 hrs post transfection cells were processed for dual labeled
immunofluorescence against Son and SF2/ASF.
(A), (E), (I), and (M): Panels show immunolabeling using affinity purified WU14
(1:1000) and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(B), (F), (J) and (N): Panels show immunolabeling of SF2/ASF using primary
antibody anti-mouse SF2/ASF (1:2500) and secondary antibody Texas-red
conjugated donkey anti mouse (1:500).
(C), (G), (K) and (O) are merge panels showing immunolabeling of Son and
SF2/ASF.
(D), (H), (L) and (P) Panels where DNA was stained with DAPI.Bar = 5 µm.
B. NIH 3T3 mouse cells grown on coverslips were transfected with Control
oligonucleotides targeting luciferase (60 pmoles) (Q-T), Son siGenome 1
oligonucleotides (60 pmoles) (U-X) 48 hrs post transfection cells were processed
for dual labeled immunofluorescence against Son and SF2/ASF.
(Q) and (U): Panels show immunolabeling using affinity purified WU13 (1:100)
and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(R) and (V): Panels show immunolabeling of SF2/ASF using primary antibody
anti-mouse SF2/ASF (1:2500) and secondary antibody Texas-red conjugated
donkey anti mouse (1:500).
(S) and (W) are merge panels showing immunolabeling of Son and SF2/ASF.
(T) and (X) Panels where DNA was stained with DAPI. Bar = 5 µm.
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Figure 12: siRNA mediated Son depletion alters localization of SF2/ASF and
Pinin.

HeLa cells grown on coverslips were transfected with Mock (vehicle
oligofectamine) (A-D), Control oligonucleotides targeting luciferase (60 pmoles)
(E-H), and Son siGenome 4 (60 pmoles) (I-L). 48 hrs post transfection cells were
fixed and processed for dual labeled immunofluorescence against Son and Pinin.
(A), (E) and (I): Panels show immunolabeling of SF2/ASF using primary antibody
anti-mouse SF2/ASF (1:2500) and secondary antibody Texas-red conjugated
donkey anti mouse (1:500).
(B), (F) and (J): Panels show immunolabeling of Pinin using anti rabbit Pinin
antibody (1:1000) and FITC conjugated donkey anti-rabbit secondary antibody
(1:500).
(C), (G) and (K) are merge panels showing immunolabeling of SF2/ASF and
Pinin.
(D), (H) and (L): Panels where DNA was stained with DAPI.Bar = 5 µm.
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Figure 13: Transfection of siRNA targeted against Son depletes Son mRNA
levels but does not alter protein levels of splicing factors.
A. RNA was extracted from HeLa cells treated with Mock (vehicle), Control oligo
(luciferase) (60 pmoles) and Son siRNAs (1 or 4) (60 pmoles) 48 hrs posttransfection. Semi-quantitative PCR was performed to evaluate the transcript
levels of Son and GAPDH.
Son mRNA was almost completely depleted after Son siRNA treatment by both
oligos targeting Son (lanes 4 and 5) as compared to the mock (lane2) and control
oligo transfected cells (lane 3). The levels of GAPDH did not change in any of the
treatments. None of the transcripts were observed when reverse transcriptase
was omitted from the reaction (lane1).
B. A duplicate siRNA experiment was performed and protein was extracted from
each of the samples by using Laemmli buffer. Equal amount of protein was
loaded on a 7% gel and transferred on to nitrocellulose. Immunoblotting was
performed by using primary antibodies targeting SF2/ASF (1:100), U1-70K
(1:100) and beta-actin (1:10,000). Horseradish peroxidase conjugated donkey
anti mouse antibody (1:50,000) was used as a secondary.
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Figure 14: siRNA mediated Son depletion alters localization of SC35-YFP.
HeLa cells having a stable integration of SC35-YFP, grown on coverslips, were
transfected with Mock (vehicle oligofectamine) (A-D), Control oligonucleotides
targeting luciferase (60 pmoles) (E-H), Son siGenome 1 oligonucleotides (60
pmoles) (I-L) and Son siGenome 4 (60 pmoles) (M-P). 48 hrs post transfection
cells were fixed with 2% paraformaldehyde and processed for
immunofluorescence against Son.
(A), (E), (I), and (M): Panels show immunolabeling using affinity purified WU14
(1:1000) and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(B), (F), (J) and (N): Panels show localization of SC35-YFP.
(C), (G), (K) and (O) are merge panels showing immunolabeling of Son and
SC35-YFP.
(D), (H), (L) and (P) Panels where DNA was stained with DAPI. Bar = 5 µm.
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Figure 15: siRNA mediated Son depletion alters localization of YFP-Magoh
in nuclear speckles to a doughnut shape phenotype.
HeLa cells were transfected with YFP-Magoh (10 µg) using the calcium
phosphate method. 48 hrs after transfection of DNA the cells were seeded on
coverslips and were transfected with Mock (vehicle oligofectamine) (A-D),
Control oligonucleotides targeting luciferase (60 pmoles) (E-H), and Son
siGenome 4 oligonucleotides (60 pmoles) (I-L). 48 hrs post transfection of the
siRNA oligos cells were fixed with 2% paraformaldehyde and processed for
immunofluorescence against Son.
(A), (E) and (I): Panels show immunolabeling using affinity purified WU14
(1:1000) and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(B), (F) and (J): Panels show localization of YFP-Magoh.
(C), (G) and (K) are merge panels showing immunolabeling of Son and SC35YFP.
(D), (H) and (L): Panels where DNA was stained with DAPI. Bar = 5 µm.
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Son depletion alters localization of polyadenalyted RNA in nuclear
speckles
RNA fluorescence in situ hybridization (RNA-FISH) with an oligo-dT probe
was used to label the stable pool of polyadenalyted RNA found in nuclear
speckles. This RNA also reorganized into the doughnut shape phenotype after
Son depletion (Figure 16, arrows panels E), whereas it showed normal nuclear
speckle colocalization with SF2/ASF (Figure 16, arrows panels A and B) in
control oligo transfected HeLa cells. Overall results from these set of experiments
suggest that all the nuclear speckle components tested reorganize into doughnut
shaped phenotype after Son depletion.
Son depletion causes a direct reorganization of nuclear speckles.

HeLa cells stably expressing YFP-SF2/ASF were used to visualize nuclear
speckle dynamics in Son-depleted cells. Time-lapse imaging indicated initial
changes in speckle morphology began 15 to 20 hrs following siRNA treatment.
To be certain that the transition of nuclear speckles from normal to the doughnut
shaped phenotype would be captured we performed time lapse microscopy on
living YFP-SF2 cells beginning thirteen hours post Son siRNA 4 transfection.
These cells showed the dynamic change of the regular nuclear speckle
morphology to a doughnut shaped phenotype by eighteen hours after
transfection of Son siRNA duplexes (Figure 17, arrows panels A to F). These live
cell experiments also showed that individual nuclear speckles change directly
into the doughnut shaped morphology of the speckles after Son depletion, and
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Figure 16: siRNA mediated Son depletion alters localization of SF2/ASF and
polyA+ RNA in nuclear speckles.

HeLa cells grown on coverslips were transfected with Control oligonucleotides
targeting luciferase (60 pmoles) (A-D), or Son siGenome 4 (60 pmoles) (E-H). 24
hrs post transfection cells were fixed and processed for RNA FISH with a Texas
red conjugated probe for poly A + RNA and immunofluorescence against
SF2/ASF.
(A) and (E) (green): Panels show RNA-FISH labeling of poly A + RNA.
(B) and (F) (red): Panels show immunolabeling of SF2/ASF using primary
antibody anti-mouse SF2/ASF (1:2500) and secondary antibody Cy-5 conjugated
donkey anti mouse (1:500).
(C) and (G) are merge panels showing immunolabeling of SF2/ASF and RNA
FISH.
(D) and (H): Panels where DNA was stained with DAPI. Bar = 5 µm.
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Figure 17: siRNA mediated depletion of Son causes a direct reorganization
of nuclear speckles.
Time lapse microscopy performed on a HeLa cells with a stable integration of
YFP-SF2/ASF 13 hrs after Son siRNA4 transfection.
Images were acquired every 10 min. Arrows show that the speckle morphology
has not changed at 13 hrs (A, arrow), but by 16 hrs the same nuclear speckle
has started changing into the doughnut shaped phenotype (D, arrow) and has
completely changed into a doughnut shaped phenotype by 18 hrs (F, arrow). The
region of the nuclear speckle (A-F, boxes) has been enlarged for ease of viewing
the change in speckle morphology at each time point.
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that the doughnut shaped phenotype observed after Son depletion is not an
artifact of fixation or the microscopy techniques used.
Son is required for nuclear speckle components to be targeted to nuclear
speckles after transcription inhibition.
The doughnut shaped nuclear speckle morphology is a very different
phenotype from that observed when RNA polymerase II transcription is inhibited
by α-amanitin. Upon α-amanitin treatment, nuclear speckles become larger and
rounded (Lamond & Spector, 2003), presumably because in absence of premRNA targets, all of the speckle components default to their storage sites (i.e.
nuclear speckles). Endogenous Son behaved similar to U1-70K (Figure 18,
arrows panel F) after α-amanitin treatment and showed larger and rounded
speckles (Figure 18, arrows panel E) as compared to the speckles observed
(Figure 18, arrows panels A and B) in the absence of α-amanitin. This result
suggests that the doughnut shaped phenotype is not a result of RNA polymerase
II transcription inhibition.
When Son depleted HeLa cells were treated with α-amanitin, speckle
component U1-70K did not localize to nuclear speckles (Figure 19, arrows panel
F and J), as compared to cells where there was not a complete loss of Son
(Figure 19, arrowheads panel E and I) where U1-70K organizes in doughnut
shaped nuclear speckles (Figure 19, arrowheads F and J). By comparison,
nuclear speckles were larger and spherical in control oligo (Figure 19, arrows A
and B) transfected cells. The fact that the speckle components could not default
back to nuclear speckles after amanitin treatment which followed Son depletion
suggested that Son is important for the nuclear speckle components to return to
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nuclear speckles after transcription inhibition. This conclusion was further
strengthened by the observation in cells with incomplete Son depletion that
showed that the speckle factors reorganized into larger doughnut shaped
speckles.
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Figure 18: The change in speckle morphology after Son depletion is not a
result of transcription inhibition.
HeLa cells grown on coverslips were treated with α-amanitin (50 µg/ml) for 6 hrs
to inhibit transcription (E-H) and untreated HeLa cells were used as a control (AD). The cells were then processed using dual labeled immunofluorescence for
localization of Son and U1-70K snRNP protein.
(A) and (E): Panels show immunolabeling using affinity purified WU14 (1:1000)
and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(B) and (F): Panels show immunolabeling of U1-70K snRNP protein using
primary antibody anti-mouse U1-70K snRNP protein (1:100) and secondary
antibody Texas-red conjugated donkey anti mouse (1:500).
(C) and (G) are merge panels showing immunolabeling of Son and U1-70K
snRNP protein.
(D) and (H) are panels where DNA was stained with DAPI. Bar = 5 µm.
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Figure 19: Son is required for nuclear speckle components to be targeted
to nuclear speckles after transcription inhibition.
HeLa cells grown on coverslips were transfected with Control oligonucleotides
targeting luciferase (60 pmoles) (A-D), Son siGenome 1 oligonucleotides (60
pmoles) (E-H) and Son siGenome 4 (60 pmoles) (I-L). Forty-two hours posttransfection, transcription was inhibited by addition of α-amanitin (50 µg/ml) for
six hours and then cells were fixed and processed for dual immunolocalization of
Son and U1-70K snRNP protein.
(A), (E), and (I): Panels show immunolabeling using affinity purified WU14
(1:1000) and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(B), (F), and (J): Panels show immunolabeling of U1-70K snRNP protein using
primary antibody anti-mouse U1-70K snRNP protein (1:100) and secondary
antibody Texas-red conjugated donkey anti mouse (1:500).
(C), (G), and (K): Merge panels showing immunolabeling of Son and U1-70K
snRNP protein.
(D), (H), and (L): Panels where DNA was stained with DAPI. Bar = 5 µm.
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Nuclear speckle phenotype observed after Son depletion is rescued by
YFP-siR-Son
Although the results of all the siRNA mediated Son depletion experiments
by using two different siRNA duplexes targeting different regions of Son, followed
by immunolabeling of speckle components showed a change in speckle
morphology. We wanted to show that this change in speckle morphology was a
direct effect of Son depletion. An siRNA-resistant YFP-Son was constructed in
which the region of Son that corresponds to the nucleotides targeted by the most
potent Dharmacon siRNA duplexes that target Son (siRNA oligo siGENOME 4)
has been changed at seven nucleotide positions by site-directed mutagenesis.
This siRNA resistant Son construct (YFP-siR-Son) produced Son mRNA that was
refractory to treatment with Son siGENOME 4 siRNA duplex. This rescue
construct was transfected in HeLa cells 48 hrs prior to transfection with mock,
control and Son siRNA duplex 4 treatment. In parallel, the same experiment was
carried out with the non-resistant YFP-Son transfected cells as a control, as the
mRNA made by this exogenous YFP-Son could be targeted by RNAi. There was
no reorganization of SF2/ASF when parental HeLa cells were treated with mock
or control oligo (Figure 20B, arrows panels B and F) and parental cells treated
with Son siGENOME4 showed reorganization of nuclear speckles to a doughnut
shaped phenotype (Figure 20B, arrow panel J). However HeLa cells protected by
expression of YFP-siR-Son showed normal nuclear speckle morphology
compared to untransfected neighbors (Figure 20B, arrowhead panel J).
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RNA extracted from YFP-Son and YFP-siR-Son cells transfected with
siRNA was used to perform semi-quantitative RT-PCR to validate depletion of
endogenous Son by using primers targeting the 3` untranslated region of Son
and also to show expression of YFP-siR-Son by using primers targeting YFP
(Figure 20). GAPDH was used as a loading control for all the samples. Neither
mRNA was detected when reverse transcriptase was omitted from the reaction
(Figure 20A, all panels, lanes 1 and 5). Endogenous Son mRNA was reduced in
cells treated with siGENOME 4 (Figure 20A, top panel, lanes 4 and 8) as
compared to mock (Figure 20A, top panel, lanes 2 and 6) and control oligo
(Figure 20A, top panel, lanes 3 and 7) including cells expressing YFP-Son and
YFP-siR-Son. The YFP-siR-Son was resistant to the siRNA treatment (Figure
20A, middle panel, lane 8) but YFP-Son level was reduced by this treatment
(Figure 20A, middle panel, lane 4). GAPDH mRNA expression was unchanged in
all the samples (Figure 20A, bottom panel all lanes). These results demonstrate
that the reorganization of nuclear speckles to a doughnut shaped phenotype is a
direct effect of Son depletion, since the phenotype can be rescued by exogenous
siRNA resistant Son.
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Figure 20: Donut shaped phenotype is rescued by YFP-siR-Son
HeLa cells were transiently transfected with YFP-tagged siRNA-resistant Son
(YFP-siR-Son) or wild type YFP-Son using calcium phosphate. 48 hrs post
transfection the cells were trypsinized and plated for duplicate siRNA knock down
experiments to monitor speckle morphology using immunofluorescence with
antibodies targeting SF2/ASF and to study the cell population using RT-PCR.
Cells were harvested for both experiments after 48 hrs of siRNA treatment.
A. Semi quantitative RT-PCR was performed using primers targeting 3`
untranslated region of endogenous Son mRNA (Son), primers targeting
the YFP region to identify exogenous Son (YFP-Son/-siR-Son) and
GAPDH was used as a loading control. Neither mRNA is detected when
reverse transcriptase was omitted from the reaction (lanes 1 and 5).
Endogenous Son mRNA expression was reduced when treated with
siGenome 4 (lanes, 4 and 8) for Son as compared to mock (lanes, 2 and
6) and control oligo (lanes, 3 and 7) treated samples of YFP-Son and
YFP-siR-Son. The exogenous Son was resistant to the siRNA treatment in
the samples of YFP-siR-Son (lane 4, middle panel) but was not resistant
in the YFP-Son samples (lane 8, middle panel). GAPDH mRNA
expression was unchanged in all the samples.
B. HeLa cells transfected with YFP-siR-Son grown on coverslips were
transfected with Mock (vehicle oligofectamine) (A-D), Control
oligonucleotides targeting luciferase (60 pmoles) (E-H), and Son
siGenome 4 (60 pmoles) (I-L).
(A), (E) and (I): Panels show YFP-siR-Son localizes to nuclear speckles.
(B), (F) and (J): Panels show immunolabeling of SF2/ASF using primary
antibody anti-mouse SF2/ASF (1:2500) and secondary antibody Texas-red
conjugated donkey anti mouse (1:500).
(C), (G) and (K) are merge panels showing immunolabeling of YFP-siR-Son
and SC35-YFP.
(D), (H) and (L): Panels where DNA was stained with DAPI. Bar = 5 µm.
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CHAPTER 4
The repeat region of Son is important to maintain
nuclear speckle integrity
We hypothesized that the unique repeat motifs in Son maintain speckle
integrity by providing a molecular scaffold for nuclear speckle components. To
determine the regions of Son that are important in maintaining nuclear speckle
integrity, carboxy-terminal deletion mutants were generated to correspond to
putative domain boundaries (Figure 2). These mutants were chosen because
deletion of consecutive domains can help to determine which regions of Son are
important for maintaining organization of nuclear speckles.
These deletion mutants of Son were made from the parental YFP-siR-Son
cDNA construct, as the 5’ end of the Son mRNA encoded by this construct is
resistant against the siRNA oligo 4. Deletion mutants were made using
convenient restriction sites residing near domain boundaries (Figure 2). Nuclear
speckle localizaton of these mutants was determined by colocalization with
antibodies against SF2/ASF. The deletion mutants, YFP-Son (full-length), or
YFP-siR-Son (full-length) were transiently transfected into HeLa cells. YFP-Son
and YFP-siR-Son were used as negative and positive controls, for rescue of the
doughnut shaped phenotype respectively. Forty eight hours post-transfection of
these cDNA constructs, cells were split for two parallel siRNA transfections. RNA
was extracted from one set and used for RT-PCR to determine the level of
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expression of endogenous and exogenous Son, while the second set was used
for microscopy.
Deletion mutants are resistant to Son siRNAs
Semi-quantitative RT-PCR was used to assess the expression of rescue
constructs and endogenous Son following Son siRNA depletion. Endogenous
Son mRNA was detected with primers targeting the 3` untranslated region of
Son, and was reduced when cells were treated with Son siRNA oligo duplexes 1
or 4 (Figure 21A and Figure 22A, middle panel, lanes 4 and 5) as compared to
mock (Figure 21A and Figure 22A, middle panel, lane 2) and control oligo (Figure
21A and Figure 22A, middle panel, lane 3). Expression of the exogenous mRNA
was evident when observed by semi-quantitative RT-PCR using primers for the
YFP region. Note that because the constructs YFP-siR-Son N-RS (1-2008) and
YFP-siR-Son N-Repeats (1-1493) are not resistant to siRNA oligo 1 against Son,
we could not detect these two exogenous Son transcripts after treatment of cells
with this siRNA oligo duplex (Figure 21A and Figure 22A, top panels, lane 4).
YFP-siR-Son (1-2008) and YFP-siR-Son (1-1493) were resistant to siRNA 4
(Figure 21A and Figure 22A, top panels, lane 5) but not to siRNA oligo1 ((Figure
21A and Figure 22A, top panels, lane 4). Neither mRNA was detected when
reverse transcriptase was omitted from the reaction (Figure 21A and Figure 22A
all panels lane 1). GAPDH mRNA expression was unchanged in all the samples
(Figure 21A and Figure 22A, bottom panels). YFP-siR-Son (1-332) was
inherently resistant against Son siRNA oligo1 as the region targeted by Son
siRNA duplexes is absent in this mutant (Figure 23A, top panels lanes 4 and 5).
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Endogenous Son expression in YFP-siR-Son (1-332) transfected cells was
reduced when treated with siGENOME 1 or 4 (Figure 23A, middle panel, lanes 4
and 5). GAPDH mRNA was used as a loading control and showed equal loading
of RNA (Figure 23A, bottom panels). Neither mRNA was detected when reverse
transcriptase was omitted from the reaction (Figure 23A, all panels, lane 1).
The repeats are required to maintain nuclear speckle structural integrity
Rescue of nuclear speckle morphology was assessed by indirect
immunofluorescence with antibodies against SF2/ASF. HeLa cells expressing the
deletion mutant YFP-siR-Son N-RS (1-2008) showed nuclear speckle localization
of this mutant (Figure 21B, panels A, E and I). The YFP-siR-Son (1-2008)
transfected

cells

showed

normal

nuclear

speckle

organization,

while

neighbouring untransfected cells had a doughnut shaped nuclear speckle (Figure
21B, arrowhead panel J). This suggested that the putative RNA binding domains
(the G-patch and the DS-RBD) of Son are not required for maintaining the
structural integrity of nuclear speckles. These domains might be important for
other functions such as interaction with RNA as shown by our collaborators
(Tripathi et al., 2010). The putative RNA binding domains of Son were required to
maintain localization of non-coding RNA MALAT1 to nuclear speckles (Tripathi et
al., 2010). It is also possible that these putative RNA interacting domains may be
important in performing other functions such as splice site recognition discussed
later in Aim 2 and are not required for maintaining speckle integrity.
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YFP-siR-Son N-Repeats (1-1493) also localized to nuclear speckles
(Figure 22B, panels; A, E and I) and showed normal nuclear speckle phenotype
after Son siRNA 4 treatment (Figure 22B, arrowhead panel J). Adjacent cells not
transfected with YFP-Son-siR (1-1493) treated with siGENOME4 for Son show
the reorganization of nuclear speckles to a doughnut shaped phenotype (Figure
22B, arrows panel J) as compared to the cells transfected with mock and control
oligo. Because YFP-siR-Son (1-1493) transfected cells show rescue of nuclear
speckles this suggests that the RS domain of Son is not required for maintaining
nuclear speckle integrity function of Son. YFP-siR-Son (1-1493) localized to
nuclear speckles even though the RS domain, the nuclear speckle targeting
sequence, is absent in this deletion mutant. This might be because the repeat
region present in this deletion mutant has a lot of serine and arginines and these
might be performing a similar function as the RS domain, to help recruit YFP-siRSon (1-1493) to nuclear speckles.
In contrast, YFP-siR-Son N-noRpts (1-332) (Figure 23) did not localize to
nuclear speckles (Figure 23B, panels; A, E and I). Cells transfected with YFPSiR-Son (1-332) treated with siGENOME4 for Son show the reorganization of
nuclear speckles to a doughnut shaped phenotype (Figure 23B, arrows panel J)
as compared to the normal nuclear speckle in cells transfected with mock and
control oligo. YFP-siR-Son (1-332) did not rescue the phenotype change
observed in the untransfected cells (Figure 23B, arrowhead panel J). The rescue
of the doughnut shaped phenotype by YFP-siR-Son (1-1493) but not by YFP-siR-
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Son (1-332) suggests that the repeats from 332-1493 play an important role in
structural integrity of nuclear speckles, a key function of Son.
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Figure 21: Donut shaped phenotype is rescued by YFP-siR-Son (1-2008)
HeLa cells were transiently transfected with carboxy terminal deletion mutant
YFP-tagged siRNA-resistant Son (1-2008) (YFP-siR-Son 1-2008) using calcium
phosphate. 48 hrs post transfection the cells were trypsinized and plated for
duplicate siRNA knock down experiments to monitor speckle morphology using
immunofluorescence with antibodies targeting SF2/ASF and to study the cell
population using RT-PCR. Cells were harvested for both experiments after 48 hrs
of siRNA treatment.
A.
Semi quantitative RT-PCR was performed using primers targeting 3`
untranslated region of endogenous Son mRNA (Son), primers targeting
the YFP region to identify exogenous Son (YFP-siR-Son (1-2008)) and
GAPDH was used as a loading control. Neither mRNA is detected when
reverse transcriptase was omitted from the reaction (lane 1).
Endogenous Son mRNA expression was reduced when treated with
siGenome 1 or 4 (lanes, 4 and 5) for Son as compared to mock (lane, 2)
and control oligo (lane, 3). The exogenous Son was resistant to the siRNA
treatment in the samples of YFP-siR-Son (1-2008) (lane 5, top panel) but
was not resistant when treated with siRNA1 (lane 4, top panel). GAPDH
mRNA expression was unchanged in all the samples.
B. HeLa cells transfected with YFP-siR-Son (1-2008) grown on coverslips
were transfected with Mock (vehicle oligofectamine) (A-D), Control
oligonucleotides targeting luciferase (60 pmoles) (E-H), and Son
siGenome 4 (60 pmoles) (I-L).
(A), (E) and (I): Panels show YFP-siR-Son (1-2008) localizes to nuclear
speckles.
(B), (F) and (J): Panels show immunolabeling of SF2/ASF using primary
antibody anti-mouse SF2/ASF (1:2500) and secondary antibody Texas-red
conjugated donkey anti mouse (1:500).
(C), (G) and (K) are merge panels showing immunolabeling of YFP-siR-Son
(1-2008) and SC35-YFP.
(D), (H) and (L): Panels where DNA was stained with DAPI. Bar = 5 µm.

96

A
A.

B
B.

97

Figure 22: Donut shaped phenotype is rescued by YFP-siR-Son (1-1493)
HeLa cells were transiently transfected with carboxy terminal deletion mutant
YFP-tagged siRNA-resistant Son (1-1493) (YFP-siR-Son 1-1493) using calcium
phosphate. 48 hrs post transfection the cells were trypsinized and plated for
duplicate siRNA knock down experiments to monitor speckle morphology using
immunofluorescence with antibodies targeting SF2/ASF and to study the cell
population using RT-PCR. Cells were harvested for both experiments after 48 hrs
of siRNA treatment.
A. Semi quantitative RT-PCR was performed using primers targeting 3`
untranslated region of endogenous Son mRNA (Son), primers targeting
the YFP region to identify exogenous Son (YFP-siR-Son (1-1493)) and
GAPDH was used as a loading control. Neither mRNA was detected when
reverse transcriptase was omitted from the reaction (lane 1).
Endogenous Son mRNA expression was reduced when treated with
siGenome 1 or 4 (lanes, 4 and 5) for Son as compared to mock (lane, 2)
and control oligo (lane, 3). The exogenous Son was resistant to the siRNA
treatment in the samples of YFP-siR-Son (1-1493) (lane 5, top panel) but
was not resistant when treated with siRNA1 (lane 4, top panel). GAPDH
mRNA expression was unchanged in all the samples.
B. HeLa cells transfected with YFP-siR-Son (1-1493) grown on coverslips
were transfected with Mock (vehicle oligofectamine) (A-D), Control
oligonucleotides targeting luciferase (60 pmoles) (E-H), and Son
siGenome 4 (60 pmoles) (I-L).
(A), (E) and (I): Panels show YFP-siR-Son (1-1493) localizes to nuclear
speckles.
(B), (F) and (J): Panels show immunolabeling of SF2/ASF using primary
antibody anti-mouse SF2/ASF (1:2500) and secondary antibody Texas-red
conjugated donkey anti mouse (1:500).
(C), (G) and (K) are merge panels showing immunolabeling of YFP-siR-Son
(1-1493) and SC35-YFP.
(D), (H) and (L): Panels where DNA was stained with DAPI. Bar = 5 µm.
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Figure 23: Donut shaped phenotype is not rescued by YFP-siR-Son (1-332).
HeLa cells were transiently transfected with carboxy terminal deletion mutant
YFP-tagged siRNA-resistant Son(1-332) (YFP-siR-Son 1-332) using calcium
phosphate. 48 hrs post transfection the cells were trypsinized and plated for
duplicate siRNA knock down experiments to monitor speckle morphology using
immunofluorescence with antibodies targeting SF2/ASF and to study the cell
population using RT-PCR. Cells were harvested for both experiments after 48 hrs
of siRNA treatment.

A. Semi quantitative RT-PCR was performed using primers targeting 3`
untranslated region of endogenous Son mRNA (Son), primers targeting
the YFP region to identify exogenous Son (YFP-siR-Son (1-332)) and
GAPDH was used as a loading control. Neither mRNA is detected when
reverse transcriptase was omitted from the reaction (lane 1).
Endogenous Son mRNA expression was reduced when treated with
siGenome 1 or 4 (lanes, 4 and 5) for Son as compared to mock (lane, 2)
and control oligo (lane, 3). The exogenous Son was resistant to the siRNA
treatment in the samples of YFP-siR-Son (1-332) (lane 4 and 5, top panel)
GAPDH mRNA expression was unchanged in all the samples.
B. HeLa cells transfected with YFP-siR-Son (1-332) grown on coverslips
were transfected with Mock (vehicle oligofectamine) (A-D), Control
oligonucleotides targeting luciferase (60 pmoles) (E-H), and Son
siGenome 4 (60 pmoles) (I-L).
(A), (E) and (I): Panels show YFP-siR-Son (1-332) does not localize to
nuclear speckles.
(B), (F) and (J): Panels show immunolabeling of SF2/ASF using primary
antibody anti-mouse SF2/ASF (1:2500) and secondary antibody Texas-red
conjugated donkey anti mouse (1:500).
(C), (G) and (K) are merge panels showing immunolabeling of YFP-siR-Son
(1-332) and SC35-YFP.
(D), (H) and (L): Panels where DNA was stained with DAPI. Bar = 5 µm.
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CHAPTER 5
Son is important for cell cycle progression.
Son depleted HeLa cells arrest at metaphase
Son-depleted cells were less adherent when observed by phase contrast
microscopy, and a Vicell count of the Son-depleted cells showed that cells were
growing at a slower rate as compared to the mock and control oligo treated cells
(Figure 24A). This result was suggestive that Son depletion interferes with cell
growth. Flow cytometry analysis of asynchronous HeLa cells showed that there
was a 12% increase of cells in G2/M phase of the cell cycle in Son depleted cells
and a corresponding decrease of about 12% of cells in G1 phase 48 hrs after
siRNA transfection. There was no significant change in the cell cycle distribution
of the mock and control oligo transfected cells (Figure 24B). These results are
representative of four separate sets of siRNA experiments, and Son depletion
was confirmed by RT-PCR in all experiments. We wanted to then distinguish if
Son depleted cells were arresting in G2 or M phase. We performed western blot
on Son-depleted samples for phosphorylation of serine 10 on histone H3, which
is upregulated during mitosis. The immunoblot showed that there was an
increase in phosphorylation of histone H3Ser10 in extracts from Son-depleted
cells (Figure 24C, lanes 3 and 4) as compared with mock (Figure 24C, lane 1)
and control extracts (Figure 24C, lane 2). Whole cell protein extract of
nocodozole treated cells arrested at metaphase was used as a positive control
for increased H3Ser (10) phosphorylation (Figure 24C, N, lane 5) in mitosis. Actin
102

immunoblotting was used to confirm equal loading of total protein in each lane
(Figure 24C, bottom panel). According to these results it appears that Son
knockdown causes cell growth to stall in mitosis and not G2 phase of cell cycle.
Collaborators in Japan (Dr. Hideaki Takata and Dr. Keichi Shibahara) also
confirmed the increase in number of cells in mitosis by performing mitotic indices
after treating HeLa cells expressing H2B-GFP siRNA oligo against Son, and
comparing them to mock and control oligos. There was a 9% increase in mitotic
cells at 48 hrs after Son siRNA duplex transfection which agreed with my flow
cytometry data.

They also confirmed that the number of prometaphase

/metaphase cells nearly doubled while there is a decrease in the number of
anaphase and telophase cells as compared to control and mock cells. This data
suggests that Son is necessary for normal cell cycle progression and that the
absence of Son causes mitotic arrest at metaphase (Sharma et al., 2010).
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Figure 24: Son depletion causes HeLa cells to arrest in mitosis.
Sixteen sets (mock, control oligo, Son siRNA 1 and Son siRNA4) of HeLa cells
were seeded on six well dishes for a time point experiment to compare cell
counts and DNA analysis of Son siRNA transfected cells to mock and control
oligo transfected cells. At each time point the cells were trypsinized and collected
in one ml of DMEM for Vicell to obtain cell counts, or RNA extraction to ascertain
levels of Son depletion, or fixed with ethanol for DNA analysis.
A. Cell growths over time by Vicell shows that Son depleted cells do not divide as
much as the mock and control transfected cells after 48 hrs of siRNA
transfection. The data represents average numbers of cells from three separate
groups of experiments. The error bars represent the standard error at each time
point value.
B. DNA analysis of the siRNA transfected samples after 48 hrs. The data is
representative of one of the four DNA analyses performed. Asynchronously
growing HeLa cells were used as a control for setting the gates for all stages of
cell cycle using DNA content. Flowcytometery graphs are shown for various
stages of cell cycle for cells transfected with mock, control oligo, Son siRNA1 or
Son siRNA4. Table represents the percent value of cells in each stage of cell
cycle.
C. Cells transfected with mock, control, Son siRNA1 and Son siRNA4 were
extracted in Laemmli buffer for immunoblot analysis to gauge the levels of
histone H3 modification (serine 10 phosphorylation) and actin. Cells treated with
nocodozole were used as a positive control.
There was an increase in phosphorylation of histone H3Ser (10) in extracts from
Son-depleted cells (lanes 3 and 4) as compared with mock (lane 1) and control
extracts (lane 2). Extract from nocodozole arrested HeLa cells (N, lane 5) also
show elevated H3 Ser (10) P in mitosis. Actin immunoblotting was used to
confirm equal loading of total protein in each lane.
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Metaphase arrest observed after Son depletion is not restricted to HeLa
cells
HEK 293 cells show a similar growth arrest as seen in HeLa cells upon
Son depletion. Son depletion in HEK 293 cells was carried out in triplicate sets by
transfecting siRNA1 or siRNA4 for 48 hours. Quantitative RT-PCR showed that
there was a five-fold decrease in Son mRNA levels after siRNA treatments as
compared to the control oligo transfected cells (Figure 25C). The samples of both
GAPDH and Son were run on a polyacrylamide gel to verify that single products
were obtained in each of the QRT-PCR reactions (Figure 25C). Son depleted
asynchronous HEK 293 cells showed a similar (8-9%) increase of cells in G2/M
phase as compared to control oligo transfected cells, which was similar to what
we observed in Son-depleted HeLa cells (Figure 25A). There was also an
increase in phosphorylation of histone H3Ser (10) in extracts from Son-depleted
cells as compared with control extracts. Extract from nocodazole arrested
HEK293 cells and HeLa cells (Figure 25B , lanes 293N and HeLaN) were used
as controls to show elevated H3 Ser(10)P in mitosis. Actin immunoblotting was
used to confirm equal loading of total protein in each lane (Figure 25B, bottom
panel, all lanes). These results suggests that the cell growth defects observed
after Son depletion are not limited to a single cell type suggesting that Son may
regulate the cell cycle in many cell types.
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Figure 25: Son depletion causes HEK 293 cells to arrest in mitosis.

Nine sets (control oligo, Son siRNA 1 and Son siRNA4) of HEK 293 cells were
seeded on six well dishes for 48 hrs to compare DNA content of Son siRNA
transfected cells to mock and control oligo transfected cells. The cells were
trypsinized and RNA extraction was performed to ascertain levels of Son
depletion, or fixed with ethanol for DNA analysis or protein was extracted for
immunoblotting with actin and histone H3 modification (serine 10
phosphorylation).
A. DNA analysis of the siRNA transfected samples after 48 hrs. The data are
representative of one of the three DNA analyses performed. Asynchronous
growing HEK 293 cells were used as a control for setting the gates for all stages
of cell cycle using DNA content. Flowcytometery graphs shown for various
stages of cell cycle for cells transfected with control oligo, Son siRNA1 or Son
siRNA4. Table represents the percent value of cells in each stage of cell cycle.

B. Cells transfected with mock, control, Son siRNA1 and Son siRNA4 were
extracted in Laemmli buffer for immunoblot analysis to gauge the levels of
histone H3 modification (serine 10 phosphorylation) and actin. Cells treated with
nocodozole were used as a positive control.
There was an increase in phosphorylation of histone H3Ser (10) in extracts from
Son-depleted cells as compared with control extracts. Extract from nocodozole
arrested HEK293 cells and HeLa cells (293N, and HeLaN) also show elevated
H3 Ser (10) P in mitosis. Actin immunoblotting was used to confirm equal loading
of total protein in each lane.

C. QRT-PCR performed with 100ng of RNA from control, and Son siRNA
transfected samples with GAPDH as an internal control show that there is a fivefold decrease in Son mRNA levels after siRNA treatments as compared to the
control oligo transfected cells. The samples of both GAPDH and Son were run on
a polyacrylamide gel to verify that a single product was obtained in the QRTPCR.
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CHAPTER 6
Son has a role in pre-mRNA transcription and splicing
Son localizes at transcription sites along with other splicing factors.
While Son is reported as a nuclear speckle protein (Mintz et al., 1999;
Saitoh et al., 2004; Sharma et al., 2010), and it is present in the nuclear insoluble
fraction (Takata et al., 2009), it was unclear if Son is also recruited to
transcription sites. To test this possibility we used HeLa cells stably expressing a
rat beta-tropomyosin minigene (HeLa BTM cells) (Prasanth et al., 2003) in which
the reporter pre-mRNA is detected primarily at one transcription site in each
nucleus. Alternative splicing of beta-tropomyosin minigene transcripts has been
extensively studied (Helfman et al., 1988; Guo et al., 1991; Caceres et al., 1994),
and exon 6 of the minigene is alternatively spliced in some cell types (Helfman et
al., 1988; Guo et al., 1991; Caceres et al., 1994). Also because transient
transfection of the beta-tropomyosin minigene demonstrated robust recruitment
of splicing factors to transcription foci in situ (Huang and Spector 1996), stable
integration of this reporter minigene into HeLa cells generated a constitutively
active transcription site (Prasanth et al., 2003) that makes it a very useful tool to
study alternative splicing in situ.
RNA transcripts from the minigene were visualized by using Texas-red
conjugated RNA FISH probe targeting exon 5. Dual immunofluorescence labeling
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using antibodies against endogenous Son and SF2/ASF (Figure 26) showed that
Son (Figure 26, panel C) and SF2/ASF (Figure 26, panel B) colocalize with the
reporter minigene RNA (Figure 26; panel A), suggesting that Son and SF2/ASF
are recruited to the RNA in-vivo. Similar results were observed when dual
immunofluorescence was performed after FISH with probes targeting exon 5 of
the reporter transcripts with Son and U1-70K (Figure 27). Son (Figure 27, panel
C) and U1-70K (Figure 27, panel B) colocalized with the RNA (Figure 27; panel
A), suggesting that Son and U1-70K are recruited to the RNA in-vivo. These
results suggest that in addition to being present in nuclear speckles Son is
recruited to the active transcription site along with other processing factors.
Son’s unique repeat region is necessary for recruitment to the betatropomyosin minigene transcription site.
Son has a large repetitive sequence containing unique serine-rich motifs
of unknown function. Repetitive motifs that most resemble this are found in the
CTD of the largest subunit of RNA Pol II. C-terminal deletion mutants truncated
after domain boundaries or full length YFP-Son described previously were
transfected into HeLa BTM in order to determine what regions of Son are
required for targeting Son to transcription sites. Forty-eight hrs post-transfection
the cells were seeded onto coverslips and labeled with texas red conjugated
probes targeting exon 5 of the reporter transcript. Antibodies targeting GFP were
used to label YFP-Son mutants because YFP fluorescence would not survive the
FISH procedure. YFP-Son colocalized with reporter transcripts at the
transcription site (Figure 28, panel C). YFP-Son (1-2008) containing the unique
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Figure 26: Endogenous Son and SF2/ASF colocalize with RNA of the
constitutively expressed rat beta-tropomyosin minigene stably integrated
in HeLa cells in-vivo.
HeLa cells stably expressing rat beta-tropomyosin minigene were processed for
localization of reporter RNA by performing FISH using Texas-red labeled probes
targeting exon 5. Following FISH the cells were fixed again and processed for
dual immunofluorescence for immuno-localization of Son and SF2/ASF.
(A): Panel shows RNA of the rat beta-tropomyosin minigene.
(B): Panel shows immunolocalization of SF2/ASF (anti SF2/ASF 1:2500) and
secondary antibody Texas-red conjugated donkey anti mouse (1:500).
(C): Panels show Son immunolabeling using affinity purified WU13 (1:100) and
FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(D): Panel shows DNA labeled with DAPI.
(E): Panel shows co-localization of Son and RNA.
(F) Panel shows co-localization of SF2/ASF and RNA.
(G): Panel shows co-localization between Son and SF2/ASF.
(H): Panel shows a triple merge of Son, SF2/ASF and RNA.
Son and SF2/ASF colocalizes to the rat beta-tropomyosin minigene RNA in-vivo
(arrows). Bar = 5 µm.
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Figure 27: Endogenous Son and U1-70K colocalize with RNA of the
constitutively expressed rat beta-tropomyosin minigene stably integrated
in HeLa cells in-vivo.
HeLa cells stably expressing rat beta-tropomyosin minigene were processed for
localization of reporter RNA by performing FISH using Texas-red labeled probes
targeting exon 5. Following FISH the cells were fixed again and processed for
dual immunofluorescence for immuno-localization of Son and U1-70K.
(A): Panel shows RNA of the rat beta-tropomyosin minigene.
(B): Panel shows immunolocalization of U1-70K (anti U1-70K 1:100) and
secondary antibody Texas-red conjugated donkey anti mouse (1:500).
(C): Panels show Son immunolabeling using affinity purified WU13 (1:100) and
FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(D): Panel shows DNA labeled with DAPI.
(E): Panel shows co-localization of Son and RNA.
(F) Panel shows co-localization of U1-70K and RNA.
(G): Panel shows co-localization between Son and U1-70K.
(H): Panel shows a triple merge of Son, U1-70K and RNA.
Son and U1-70K colocalizes to the rat beta-tropomyosin minigene RNA in-vivo
(arrows). Bar = 5 µm.
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Figure 28: Exogenous YFP-Son N terminus to repeats (1-1493) is recruited
to the constitutively expressed stably integrated rat beta-tropomyosin
minigene transcription site.
HeLa cells stably expressing rat beta-tropomyosin minigene were transiently
transfected with YFP-Son FL (1-2564) (A-D), YFP-Son (1-2008) (E-H), and YFPSon (1-1493) (I-L) and YFP-Son (1-332) (M-P). Forty eight hrs post transfection
the cells were seeded on coverslips and processed for localization of reporter
RNA by performing FISH using Texas-red labeled probes targeting exon 5.
Following FISH the cells were fixed again and processed for
immunofluorescence for immuno-localization for YFP-Son (anti GFP 1:100).
(A), (E), (I), and (M): Panels show immunolocalization of YFP (anti GFP 1:100)
and secondary antibody Texas-red conjugated donkey anti mouse (1:500).
(B), (F), (J) and (N): Panels show RNA of the rat beta-tropomyosin minigene.
(C), (G), (K) and (O): Panel show co-localization of YFP-Son and RNA.
(D), (H), (L) and (P): Panel show DNA labeled with DAPI.
YFP-Son (1-2564, 1-2008 and 1-1493) colocalize to the rat beta-tropomyosin
minigene transcription site in-vivo (arrows C, G and K) but YFP-Son (1-332)
(arrows, panel O) cannot colocalize to rat beta-tropomyosin transcription site.
DNA was stained with DAPI. Bar = 5 µm.
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repeats and the RS domain, but lacking the putative RNA binding regions, the
double stranded RNA binding domains and G-Patch of Son, colocalized with
beta-tropomyosin transcripts (Figure 28, panel G).YFP-Son (1-1493) containing
the unique repeats also colocalized with beta-tropomyosin transcripts (Figure 28,
panel K). However YFP-Son (1- 332), the deletion mutant of Son which only
contains the N terminus and lacks the repeats, could not recruit to the betatropomyosin reporter transcripts (Figure 28, panel O). These results suggest that
the putative RNA binding domains and the RS domain were not essential for
recruitment of Son to the active transcription site whereas Son’s repeats are
required for Son recruitment to the transcription site. The other domains such as
the RS domain and the RNA binding domains at the C-terminus of Son may be
required for other functions such as interacting with other splicing factors or with
the RNA transcripts.
Son depletion alters splicing but not transcription of the beta-tropomyosin
minigene pre-mRNA.
HeLa cells stably expressing the rat beta-tropomyosin minigene (Prasanth
et al., 2003) were transfected with two different sets of siRNA duplexes
previously shown to knock down expression of Son (Sharma et al., 2010) as well
as with mock (vehicle) and control (luciferase siRNA duplexes). Forty-eight hours
post transfection, RNA was extracted from these cells and Sybr-green based
qRT-PCR was performed to confirm Son depletion as well as to assess
transcription and splicing of the beta-tropomyosin reporter RNA. Various primer
sets targeting different exon-exon and exon-intron regions of the minigene were
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used (Figure 29B). While Son was depleted by siGENOME1 and siGENOME4
duplexes (Figure 29C), there was no difference in beta-tropomyosin reporter
RNA levels between Son depleted and control samples regardless of the primer
set used. This suggested that there was no affect on transcription of the betatropomyosin reporter minigene following depletion of Son.
To determine if Son depletion affected splicing of beta-tropomyosin
minigene transcripts, qRT-PCR products of primers spanning exon 5 - exon 7
were applied to native polyacrylamide gel electrophoresis (Figure 30).

PCR

products from mock and control samples included unspliced transcripts, fully
spliced transcripts and transcripts in which exon 6 is skipped. Son depletion did
not change the level of unspliced product as compared with control and mock
samples suggesting that absence of Son does not alter the transcription of
reporter pre-mRNA. However, Son-depleted samples showed a major shift from
the fully spliced product to a product in which exon 6 is skipped, suggesting that
Son is important for splice site selection.
To validate these results in situ, we used a 24 nt Cy5-labeled exon
junction probe designed to hybridize to reporter transcripts only when exon 6 is
skipped. Hybridization was done in conditions that prevented control exon 5 and
exon 7 12-mer binding (see methods) (Sacco-Bubulya et al., 2002). A Texas
Red-labeled probe complimentary to beta-tropomyosin exon 5 showed unspliced
and spliced beta-tropomyosin reporter transcript labeling in control as well as
Son depleted cells. Immunofluorescence showed significantly reduced labeling in
Son depleted cells (Figure 31, panels F and K) as compared to control oligo
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treated cells (Figure 31, panel A). RNA FISH was performed with Cy-5 labeled
exon junction probe 5-7 and Texas Red-labeled exon 5 probe followed by
immunofluorescence against Son. Exon 5 probe showed beta-tropomyosin
transcription was robust in control as well as Son depleted samples (Figure 31,
panels B, G and L). However, labeling of the exon junction probe specific against
exon 5-7 was clearly detectable at beta-tropomyosin transcription sites in Son
depleted cells (Figure 31, panels H, and M) but not in control oligo transfected
samples (Figure 31, panel C). The 5-7 exon junction probe colocalized with exon
5 probes when Son was depleted (Figure 31, panels I and N). The 5-7 exon
junction probes shows no specific labeling in control cells even though qRT-PCR
results show there is some 5-7 product made in the control cells. This could be
because the qRT-PCR is a more sensitive procedure than the RNA FISH assay.
These results confirm that exon 6 is skipped in cells depleted of Son and Son is
required for the proper splice site selection on this reporter minigene.
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Figure 29: Son depletion does not change rat beta-tropomyosin transcript
levels.
A. RNA FISH performed on HeLa cells stably expressing rat betatropomyosin minigene with a Texas Red labeled probe targeting exon 5 of
the minigene.
B. Schematic representation of rat beta-tropomyosin minigene locus
integrated in HeLa cells. The rat beta-tropomyosin minigene locus
consists of four exons (E5, E6, E7, and E8). The thin line represents intron
between the exons. Primers sets are represented by letters, A (1 and 2)
spans exon5-exon7, B (1 and 2) spans exon5- intron 6, C (1 and 2) spans
intron5-exon6, and D (1 and 2) spans exon 6- intron 6.
C. HeLa cells stably expressing rat beta- tropomyosin minigene were treated
with mock (vehicle), or luciferase siRNA duplexes (60 pmoles; control), or
Son siGENOME1 siRNA duplexes (60 pmoles), or Son siGENOME4
siRNA duplexes (60 pmoles). 48 hrs post-transfection, RNA was
extracted Graph shows total amount of qRT-PCR product amplified using
various primer pairs. Regardless of primer pairs used, the amount of
reporter transcript was similar in cells treated with Son siRNA duplexes
and controls.
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Figure 30: Son depletion causes a change in splice site selection of rat
beta-tropomyosin minigene transcripts.
qRT-PCR products amplified using various primer pairs on Son depleted rat
beta-tropomyosin stably integrated HeLa cells showed no change in transcription
levels as compared to control treated cells (Fig 27 C). To look more carefully at
amplification products of primers spanning exon 5 to exon 7, were applied to
polyacrylamide gel electrophoresis. No transcripts were observed when reverse
transcriptase was omitted from the reaction. PCR products from mock and
control show samples showed unspliced transcripts, fully spliced transcripts and
transcripts in which exon 6 is skipped. Son-depleted samples showed a major
product shift from the fully spliced product to a product in which exon 6 skipped.
The absence of Son causes exon skipping on this reporter.
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Figure 31: Exon 6 skipping can be detected on the beta-tropomyosin
transcription site in situ after Son depletion.
HeLa cells stably expressing rat beta tropomyosin mine-gene were treated with
luciferase siRNA oligonucleotides (60 pmoles; control) (panels A-E), or Son
siGENOME1 siRNA oligonucleotides (60 pmoles) (panels, F-J), or Son
siGENOME4 siRNA oligonucleotides (60 pmoles) (panels, K-O). 48 hrs posttransfection, cells were fixed and processed for RNA FISH to visualize the RNA
by using probes hybridizing to exon 5 (Texas red labeled ) and exon junction
probe 5-7 (Cy5 labeled). Following FISH cells were processed for
immunolocalization of Son.
(A), (F) and (K): Panels show Son immunolabeling using affinity purified WU13
(1:100) and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(B), (G) and (L): Panels show RNA labeled with exon5 of the rat betatropomyosin minigene.
(C), (H) and (M): Panels show RNA labeled with exon5 –exon 7 junction probe of
the rat beta-tropomyosin minigene.
(D), (I) and (N): Merge panels showing co-localization between SF2/ASF and
RNA.
(E), (J) and (O): Panels show DNA labeled with DAPI. Bar = 5 µm.
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Splicing factors are recruited to the beta-tropomyosin minigene locus in
Son-depleted cells.
Depleting Son alters the organization of all nuclear speckle components
tested (Sharma et al., 2010). Since nuclear speckles are a storage and assembly
site for splicing factors, we wanted to rule out the possibility that the splice site
change we observed in the beta-tropomyosin transcripts after Son depletion was
not an effect of the altered organization of nuclear speckles that led to
significantly altered recruitment of other splicing factors to the beta-tropomyosin
transcription site. We performed RNA-FISH using Texas Red-labeled probes
targeting exon 5 of the beta-tropomyosin reporter RNA followed by dual label
immunofluorescence with antibodies against Son and SF2/ASF (Figure 32) or
Son and U1-70K (Figure 33) after Son depletion.
Son signal was nearly abolished in cells treated with Son siRNAs (Figure
32 and 33, panels F and K) as compared to cells treated with control siRNA
(Figure 32 and 33, panels A). Transcripts from the reporter minigene were
visualized after Son depletion (Figure 32 and 33, panels G and L) at levels
comparable to cells that were transfected with control oligos (Figure 32 and 33,
panels B). This was consistent with our qRT-PCR results (Figure 30). Son,
SF2/ASF and U1-70K were all recruited to the beta-tropomyosin minigene RNA
when cells were transfected with control siRNAs (Figure 32 and 33, panels C).
Interestingly, even though SF2/ASF (Figure 32, panels H and M) and U1-70K
(Figure 33, panels H and M) showed the expected change in their subnuclear
localization following Son depletion (Sharma et al., 2010), they were still recruited
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Figure 32: Son depletion does not prevent recruitment of SF2/ASF to the rat
beta-tropomyosin transcription site
HeLa cells stably expressing rat beta tropomyosin mine-gene were treated with
luciferase siRNA oligonucleotides (60 pmoles; control) (panels A-E), or Son
siGENOME1 siRNA oligonucleotides (60 pmoles) (panels, F-J), or Son
siGENOME4 siRNA oligonucleotides (60 pmoles) (panels, K-O). 48 hrs posttransfection, cells were fixed and processed for RNA FISH to visualize the RNA
and immunolocalization of Son with SF2/ASF.
(A), (F) and (K): Panels show Son immunolabeling using affinity purified WU13
(1:100) and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(B), (G) and (L): Panels show RNA of the rat beta-tropomyosin minigene.
(C), (H) and (M): Panels show immunolocalization of SF2/ASF (anti SF2/ASF
1:2500) and secondary antibody Texas-Red conjugated donkey anti mouse
(1:500).
(D), (I) and (N): Merge panels showing co-localization between SF2/ASF and
RNA.
(E), (J) and (O): Panels show DNA labeled with DAPI. Bar = 5 µm.
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Figure 33: Son depletion does not prevent recruitment of U1-70K to the to
the rat beta-tropomyosin transcription site
HeLa cells stably expressing rat beta tropomyosin mine-gene were treated with
luciferase siRNA oligonucleotides (60 pmoles; control) (panels A-E), or Son
siGENOME1 siRNA oligonucleotides (60 pmoles) (panels, F-J), or Son
siGENOME4 siRNA oligonucleotides (60 pmoles) (panels, K-O). 48 hrs posttransfection, cells were fixed and processed for RNA FISH to visualize the RNA
and immunolocalization of Son with U1-70K.
(A), (F) and (K): Panels show Son immunolabeling using affinity purified WU13
(1:100) and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(B), (G) and (L): Panels show RNA of the rat beta-tropomyosin minigene.
(C), (H) and (M): Panels show immunolocalization of SF2/ASF (anti SF2/ASF
1:2500) and secondary antibody Texas-red conjugated donkey anti mouse
(1:500).
(D), (I) and (N): Merge panels showing co-localization between SF2/ASF and
RNA.
(E), (J) and (O): Panels show DNA labeled with DAPI. Bar = 5 µm.
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to the beta-tropomyosin minigene transcription site (Figure 32 and 33, panels I
and N). These results suggest that the global nuclear speckle reorganization in
Son depleted cells does not prevent nuclear speckle components from being
recruited to transcription sites and the change in splice site selection observed in
the beta-tropomyosin minigene may be a direct result of Son depletion.
Son has a role in transcription
Proteomic analysis of nuclear speckles showed that the majority of
nuclear speckle proteins are involved in pre-mRNA processing or RNA
polymerase II transcription. It is therefore not surprising that Son is important for
regulation of pre-mRNA splicing. Here we show that transcription of the betatropomyosin minigene (under the influence of SV40 promoter) is not adversely
affected in absence of Son. We wanted to analyze whether depletion of Son
causes a change in global transcription in RNA polymerase II transcribed genes.
Bromo-UTP incorporation has been used before to look at global transcription
sites in-vivo in HeLa cells (Sacco-Bubulya and Spector, 2002; Bubulya et al.,
2004). HeLa cells were transfected with mock, control oligo, and siRNAs 1 and 4
targeting Son for 48 hrs and a control coverslip was treated with α-amanatin. αamanitin treated HeLa cells were used as a control because α-amanitin treatment
inhibits global transcription and these cells would show no Bromo-UTP
incorporation. Indirect immunofluorescence was used to visualize and compare
both Son and nascent transcripts levels using antibodies against BrdU (Sigma;
this antibody recognizes all halogenated UTP analogs) between the mock,
control, and Son depleted cells. There were no changes in the Br-UTP
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incorporation of the siRNA knock down cells (Figure 34, panels F and J ) as
compared to the mock and control oligo treated cells (Figure 34, panel B ).
Neither of these results, showing no transcription changes to beta-tropomyosin
minigene transcription after Son depletion and global Br-UTP incorporation, likely
reflects the whole story about Son`s capacity for transcription regulation. Br-UTP
incorporation may not be sensitive enough to report subtle changes in
transcription, especially if only a handful of genes are regulated by Son. Also,
Son may not regulate transcription of beta-tropomyosin minigene but could
regulate expression of other genes. Previous reports have confirmed that Son
plays a role in regulating transcription of hepatitis B virus (Sun et al., 2001) and
Son is an SR protein which has been reported to interact with splicing factor
SrRP53 (Cazalla et al. 2005). We used the U2OS (2-6-3 locus) cell line available
in the lab. The transcription at the U2OS 2-6-3 reporter locus (Figure 35A) is
inducible because it contains tetracycline response elements (TREs) that are
regulated by the activator protein (TetON). The locus is easily distinguished
between the “off” and the “on” state of transcription by its structure (Figure 35B)
(Janicki et al., 2004). There are about 200 copies of reporter transcription units in
this locus. Doxycycline regulates activation of transcription by inducing TetON to
bind to TREs. CFP-Lac repressor or YFP-Lac repressor expression enable the
visualization of chromatin at the locus. YFP-MS2 protein expression facilitates
indirect visualization of the transcribed RNA once transcription is initiated, as this
MS2 protein interacts with the stem loop structures in the reporter RNA. Also the
CFP-protein that the mRNA encodes has an SKL-peroxisome targeting
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Figure 34: Son depletion does not affect global transcription
HeLa cells grown on coverslips were transfected with Control oligonucleotides
targeting luciferase (60 pmoles) (A-D), Son siGenome 1 oligonucleotides (60
pmoles) (E-H) and Son siGenome 4 (60 pmoles) (I-L). Twenty four hours posttransfection, cells were permeabilized using digitonin and were incubated in
transcription buffer for uptake of Br-UTP in nascent RNA Pol II transcripts. A
cover-slip of HeLa cells was also treated with α-amanitin (50µg/ml) for six hours
(M-P) and was used as a control for Br-UTP incorporation. All cells were fixed
and processed for dual immunolocalization of Son and Br-UTP.
(A), (E), (I), and (M): Panels show immunolabeling using affinity purified WU14
(1:1000) and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(B), (F), (J) and (N): Panels show immunolocalization of Br-UTP (anti Brdu 1:100)
and secondary antibody Texas-red conjugated donkey anti mouse (1:500).
(C), (G), (K) and (O) are merge panels showing immunolabeling of Son and
nascent transcripts.
(D), (H), (L) and (P) Panels where DNA was stained with DAPI.
Panels (E and I) show no specific labeling of the antibody for Son after siRNA
depletion and panels (N) shows no labeling of nascent transcripts after amanitin
treatment. Panel (M) shows Son labeling showing bigger and rounded nuclear
speckles.
There is no change in level of nascent transcript between panels (B, F and J).
Bar = 5 µm.
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Figure 35: U2OS 2-6-3 gene locus is a useful tool to study gene expression.
A. Schematic representation of the U2OS 2-6-3 gene locus. (Janicki et al. 2004)
The locus is comprised of the lac operator, tetracycline response elements, a
minimal CMV promoter, CFP fused to the peroxisomal targeting signal SKL, MS2
translational operators (MS2 repeats), and a rabbit β-globin intron/exon module
cassette with a cleavage/polyadenylation signal. Expression of CFP-lac
repressor/ or YFP-lac repressor allows the DNA to be visualized and expression
of pTet-On (rtTA) in the presence of doxycycline (Dox) initiates expression from
the CMV minimal promoter. When MS2-YFP (YFP fused to the MS2 coat protein)
dimerizes and interacts with the stem loop structure of the translational operator,
it allows the transcribed RNA to be visualized. The protein generated after posttranscriptional processing is targeted to peroxisomes because of the SKL-tag,
allowing us to evaluate if post-transcriptional processing of the mRNA is
completed accurately.
B. U2OS 2-6-3 cells were transfected YFP-Lac repressor and pTet-On and after
3 hours doxycycline was added for 2.5 hours (+ Dox) to initiate transcription
which shows a decondensed gene locus (B arrow on right) and when doxycycline
is not added (-Dox) the locus stays condensed and compact (B arrow on left).
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sequence, which can be visualized to confirm that all post-transcriptional events
have occurred properly. This cell line provides a useful tool to study all aspects of
gene expression.
Son localizes to the inactive U2OS 2-6-3 gene locus.
We know that Son is recruited to the constitutively active beta-tropomyosin
minigene transcription site along with all tested pre-mRNA processing factors. All
SR proteins and splicing factors, examined thus far have been shown to be
recruited to the locus when the U2OS 2-6-3 gene locus is induced by addition of
doxycycline and transfection of pTet-ON (Janicki et al., 2004). We expected Son
to behave similar to other SR proteins. U2OS 2-6-3 cells were transfected with
CFP-Lac repressor and pTet-On and seeded on duplicate coverslips.
Doxycycline was added to one coverslip to initiate transcription while the other
coverslip did not receive doxycycline so that transcription was not initiated in
these cells. Dual label immunofluorescence was performed using antibodies
targeting Son and SF2/ASF (Figure 36). SF2/ASF was used as a positive control
as it has been shown to be recruited to the active locus (Janicki et al., 2004).
SF2/ASF localized to the active decondensed U2OS 2-6-3 gene locus (Figure
36, panel J) but not to inactive condensed locus (Figure 36, panel E).
Unexpectedly, we observed that Son localized to the inactive condensed locus
(Figure 36, panel C) but not to the active decondensed U2OS 2-6-3 gene locus
(Figure 36, panel H). This localization was also confirmed by transfecting YFPSon with CFP-Lac repressor and pTet-On in the U2OS 2-6-3 cells (Figure 37).
The cells were seeded on duplicate coverslips, one received doxycycline to
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induce transcription and other coverslip did not in order to maintain an inactive
transcription site. Immunofluorescence was performed on both the coverslips
with antibodies against SF2/ASF. YFP-Son localized to the inactive condensed
locus (Figure 37, panel C) but not with the active decondensed U2OS 2-6-3 gene
locus (Figure 37, panel H). As expected SF2/ASF localized to the active
decondensed U2OS 2-6-3 gene locus (Figure 37, panel J) but not to inactive
condensed locus (Figure37, panel E). It was evident that Son localized to
condensed inactive gene loci as we did not see SF2/ASF localizing to these
inactive gene loci, however we still wanted to confirm that there was no leaky
transcription at these gene loci. We transfected U2OS 2-6-3 cells with YFP-Son
and CFP-Lac repressor without pTet-ON and seeded cells on coverslips (Figure
38). The exclusion of pTet-ON ensures that no transcription would take place in
these cells and the 2-6-3 gene loci will remain condensed and inactive.
Immunofluorescence was performed with antibodies against SF2/ASF to serve
as a control as SF2/ASF would not localize to the gene loci in these cells. YFPSon localized to the inactive condensed locus (Figure 38, panel C) while
SF2/ASF did not localize to these gene loci (Figure 38, panel E). Endogenous
and exogenous Son both localized to the inactive decondensed U2OS 2-6-3
gene locus and did not localize when transcription was turned on. These results
suggest Son may be involved in transcription repression of this gene locus
regulated by CMV promoter.
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Figure 36: Endogenous Son localizes to the inactive but not to the active
U2OS 2-6-3 gene locus.
U2OS 2-6-3 cells were transfected with CFP-LacI and activator pTet-On using
electroporation and the cells were seeded on duplicate coverslips. Three hrs post
transfection one set was treated with 1 µg of doxycycline (F-J) to activate
transcription while nothing was added to the other set (A-E) so that there is no
transcription activation in this set. Both sets of coverslips were fixed with 2%
paraformaldehyde and processed for dual immunofluorescence for immunolocalization of Son and SF2/ASF.
Insets area shown in panels A and F.
(A) and (F): Panels show CFP-LacI localization which labels the Locus.
(B) and (G): Panels show Son immunolabeling using affinity purified WU13
(1:100) and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(C) and (H): Panels show merge to show co-localization of Son and Locus.
(D) and (I): Panels show immunolocalization of SF2/ASF (anti SF2/ASF 1:2500)
and secondary antibody Texas-red conjugated donkey anti mouse (1:500).
(E) and (J): Panels show merge to show co-localization of SF2/ASF and Locus.
Bar = 5 µm.
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Figure 37: Exogenous YFP-Son localizes to the inactive but not to the
active U2OS 2-6-3 gene locus.
U2OS 2-6-3 cells were transfected with YFP-Son using calcium phosphate
method. Forty eight hrs post-transfection of YFP-Son the cells were trypsinized
and CFP-LacI and activator pTet-On were transfected using electroporation and
the cells were seeded on duplicate coverslips. Three hrs post transfection one
set was treated with 1 µg of doxycycline (F-J) to activate transcription while
nothing was added to the other set (A-E) so that there is no transcription
activation in this set. Both sets of coverslips were fixed with 2%
paraformaldehyde and processed for immunofluorescence for immunolocalization of SF2/ASF.
Insets area shown in panels A and F.
(A) and (F): Panels show CFP-LacI localization which labels the Locus.
(B) and (G): Panels show YFP-Son localization.
(C) and (H): Panels show merge to show co-localization of YFP-Son and Locus.
(D) and (I): Panels show immunolocalization of SF2/ASF (anti SF2/ASF 1:2500)
and secondary antibody Texas-red conjugated donkey anti mouse (1:500).
(E) and (J): Panels show merge to show co-localization of SF2/ASF and Locus.
Bar = 5 µm.
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Figure 38: Exogenous YFP-Son localization to the inactive U2OS 2-6-3 gene
locus is independent of transcription activator transfection.
U2OS 2-6-3 cells were transfected with YFP-Son using calcium phosphate
method. Forty eight hrs post-transfection of YFP-Son the cells were trypsinized
and CFP-LacI was transfected using electroporation and the cells were seeded
on coverslips. Five hrs following the second transfection coverslips were fixed
with 2% paraformaldehyde and processed for immunofluorescence for immunolocalization of SF2/ASF.
Insets area shown in panels A and F.
(A): Panels show CFP-LacI localization which labels the Locus.
(B): Panels show YFP-Son localization.
(C): Panels show merge to show co-localization of YFP-Son and Locus.
(D): Panels show immunolocalization of SF2/ASF (anti SF2/ASF 1:2500) and
secondary antibody Texas-red conjugated donkey anti mouse (1:500).
(E): Panels show merge to show co-localization of SF2/ASF and Locus.
Bar = 5 µm.
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Son’s unique repeat region is necessary for recruitment to the U2OS 2-6-3
gene loci.
To determine which regions of Son are required for localization of Son to
inactive U2OS 2-6-3 gene loci, C-terminal deletion mutants truncated after
domain boundaries were transfected into U2OS 2-6-3 cells along with CFP-Lac
repressor and mCherry SF2/ASF without pTet-On. YFP-Son (1-2008) containing
the unique repeats and the RS domain, but lacking the putative RNA binding
regions, the double stranded RNA binding domains and G-Patch of Son,
colocalized with inactive decondensed U2OS 2-6-3 gene loci (Figure 39A, panel
C). YFP-Son (1-1493) containing the unique repeats also colocalized with
inactive de-condensed U2OS 2-6-3 gene loci (Figure 39B, panel C). However
YFP-Son (1-332), the deletion mutant of Son which only contains the N- terminus
and lacks the repeats, could not localize to the inactive decondensed U2OS 2-63 gene loci (Figure 39C, panel C). mCherry SF2/ASF did not localize to the
inactive decondensed U2OS 2-6-3 gene loci (Figure 39A, B and C, Panel E) as
expected. These data point to Son`s repeats as being required for Son
recruitment to the inactive U2OS 2-6-3 gene locus.
Son is important for gene regulation in-vivo.
To pinpoint endogenous human genes that are regulated by Son, we
analyzed Son dependent changes in gene expression profiles for both
transcription and splicing by performing an Affymetrix Exon Array 1.0 comparing
RNA profiles from Son depleted HeLa cells and Control oligo transfected HeLa
cells.
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Figure 39: Exogenous YFP-Son N-terminus to repeat region (1-1493) is
recruited to the inactive U2OS 2-6-3 gene locus
U2OS 2-6-3 cells were transfected with YFP-Son (1-2008) or (1-1493) or (1-332)
using Calcium phosphate method. Forty eight hrs post-transfection of YFP-Son
the cells were trypsinized and CFP-LacI was transfected using electroporation
and the cells were seeded on coverslips. Five hours post coverslips were fixed
with 2% paraformaldehyde and processed for immunofluorescence for immunolocalization of SF2/ASF.
A. Cells transfected with YFP-Son (1-2008).
B. Cells transfected with YFP-Son (1-1493).
C. Cells transfected with YFP-Son (1-332).
Insets area shown in panels A and F.
(A): Panels show CFP-LacI localization which labels the Locus.
(B): Panels show YFP-Son localization.
(C): Panels show merge to show co-localization of YFP-Son and Locus.
(D): Panels show immunolocalization of SF2/ASF (anti SF2/ASF 1:2500) and
secondary antibody Texas-red conjugated donkey anti mouse (1:500).
(E): Panels show merge to show co-localization of SF2/ASF and Locus.
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Son depletion was confirmed as compared to the control samples in all
five samples used for exon array (Figure 40). Exon array results suggest that
Son depletion caused a change in mRNA levels of transcripts involved in
important bio-chemical processes such as apoptosis, cell cycle regulation, Wnt
signaling, cholesterol biosynthesis, TGF beta signaling, glycogen metabolism,
smooth muscle contraction, integrin mediated cell adhesion, G protein signaling,
fatty acid synthesis, glycogen metabolism and translocation factors (Figure 41).
Son depletion caused an increase in expression level for some genes and a
decrease in expression level of other genes. This suggests that Son can
participate in both gene activation and repression. The top ten genes showing
either a decreased or increased level of transcripts are shown in Table 1. In all,
359 genes showed at least twofold upregulation and 568 genes showed a
twofold downregulation of expression after Son depletion as compared to Control
cells. The complete list of target genes is available upon request.
We validated target genes suggested by the results obtained from the
exon array. Validations by qRT-PCR showed that the cardiac muscle troponin
(TNCC1) mRNA is reduced by approximately 60% after Son depletion as
compared to the control samples (Figure 42). Results from our exon array data
show that Son depleted samples have a lower expression of cyclin dependent
kinase 5 (CDK5) which was further validated by PCR to show that the levels are
reduced by about 50% as compared to control samples (Figure 42).
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Figure 40: Son was depleted in the samples used for Exon-Array.
Son was depleted in RNA samples used for performing Affimetrix Human Exon
Array ST 1.0.Five different sets of HeLa cells were transfected with luciferase
siRNA (control), or Son siRNA 4 for forty-eight hours. RNA was extracted from
these five sets and QRT-PCR was performed to validate Son depletion. GAPDH
was used as an internal control for the PCR reaction. Son mRNA was depleted
after siRNA4 transfection (si4 lanes). No product was seen when reverse
transcriptase was absent from the reaction (-RT).
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Figure 41: Endogenous genes involved in various important functions
showing a change in mRNA levels
Pie chart categorizes the genes involved in various important biomedical
processes which show either an up-regulation or down-regulation in mRNA level
after Son is depleted. These results are predicted by using the analysis tool of
Alt-Analyse software.
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Table.1: Top ten genes showing a change in transcription after Son
depletion.
The table represents top ten genes showing the most change in transcription
levels in the Son depleted samples as compared to the control oligo transfected
cells. The top ten list was generated by taking the highest fold change as well as
the most significant changes for both up-regulation as well as down-regulation of
transcription after Son depletion using Alt-Analyse software.
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Figure 42: Son depletion changes mRNA levels for many endogenous
genes.
Validation of endogenous genes showing lower expression after Son depletion
was performed by running qRT-PCR on three different samples used in exon
array in triplicate using primers spanning the core exons of TNCC1 and CDK5.
GAPDH primers were used as an internal control. Son depleted samples showed
a reduction in both TNCC1 and CDK5 transcript levels as compared to control
samples. Polyacrylamide gel electrophoresis of the products showed a single
expected size product was obtained in each of the reactions as expected.
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Son regulates splicing of endogenous pre-mRNAs.
The exon array performed after Son depletion suggested 1061 genes
showing different exon inclusion or exclusion compared to control samples. The
top ten splice site selection changes observed in our analysis is shown in Table 2
and a complete list of changes in splice site selection is available upon request.
Among the genes with the highest fold change and highest statistical
probability were genes involved in histone modification. These were of special
interest as Son has been recently shown to be one of the key regulators of
maintenance of pluripotency of the human embryonic stem cells (Chia et al.,
2010). We chose to validate that splicing is misregulated in three of these genes;
in all cases these were genes that were unaffected at the level of transcription.
Validation was performed by running qRT-PCR products amplified using
primer pairs indicated on the schematic (Figure 43), spanning exon 8 to exon 10
of adenosine deaminase (ADA) gene, spanning exon 26 to exon 29 of histone
de-acetylase 6 (HDAC6) gene (Figure 44), and spanning exon 1 to exon 3 of
histone methyltransferase 8 (SetD8) gene (Figure 45). qRT-PCR also validated
that there was no change observed in transcript levels (Figures 43B, 44B and
45B) between the Son depleted RNA samples and control oligo transfected
samples (GAPDH oligos were used as internal control).
Amplification products of primers spanning exon 8 to exon 10 for ADA,
exon 26 to exon 29 for HDAC6 and exon 1 to exon 3 for SetD8 were applied to
polyacrylamide gel electrophoresis.

PCR products in lanes labeled C show

splicing patterns in control samples for comparison to mis-spliced or alternatively
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spliced patterns in Son depleted samples. Son-depleted samples showed a
major product shift from the fully spliced product to a product in which exon(s)
were skipped. Son depleted samples show PCR products of sizes that we expect
for splicing misregulation in transcripts for which exon 9 is skipped for ADA
(Figure 43A), exons 27 and 28 are skipped for HDAC6 (Figure 44A) and exon 2
is skipped in the case of SetD8 (Figure 45A) . In conclusion, Son depletion
causes exon skipping in this histone modyfing enzyme splice site selection invivo.
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Table.2: Top ten endogenous genes where splice site selection is changed
when Son is depleted.
The table represents top ten genes showing the most changes in splice site
selection in the Son depleted samples as compared to the control oligo
transfected cells. The top ten list was generated by taking the highest fold
change as well as the most significant changes for both exon skipping and exon
inclusion after Son depletion using Alt-Analyse software.
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Figure 43: Son depletion causes changes in splice site selection but no
changes in transcription of histone modifying enzyme ADA in-vivo.
Validation was performed by running qRT-PCR products amplified using primer
pairs indicated on the schematic spanning exon 8 to exon 10 of adenosine
deaminase gene. Amplification products of primers spanning exon 8 to exon 10
were applied to polyacrylamide gel electrophoresis. No transcripts were
observed when reverse transcriptase was omitted from the reaction. PCR
products from control show fully spliced transcripts while Son depleted samples
show transcripts in which exon 9 is skipped. Son-depleted samples showed a
major product shift from the fully spliced product to a product in which exon 9 is
skipped. The absence of Son causes exon skipping in this histone modifying
enzyme splice site selection in-vivo.
B. There was no change observed in transcripts levels between the Son depleted
RNA samples and control oligo transfected samples using GAPDH oligos as
internal control.
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Figure 44: Son depletion causes changes in splice site selection but no
changes in transcription of histone modifying enzyme HDAC6 in-vivo.
A. Validation was performed by running qRT-PCR products amplified using
primer pairs indicated on the schematic spanning exon 26 to exon 29 of histone
de-acetylase 6 gene. Amplification products of primers spanning exon 26 to exon
29 were applied to polyacrylamide gel electrophoresis. No transcripts were
observed when reverse transcriptase was omitted from the reaction. PCR
products from control show, fully spliced transcripts while Son depleted samples
show transcripts in which exons 27 and 28 are skipped. Son-depleted samples
showed a major product shift from the fully spliced product to a product in which
exons 27 and 28 are skipped. The absence of Son causes exon skipping in this
histone modifying enzyme splice site selection in-vivo.
B. There was no change observed in transcripts levels between the Son depleted
RNA samples and control oligo transfected samples using GAPDH oligos as
internal control.
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Figure 45: Son depletion causes changes in splice site selection but no
changes in transcription of histone modifying enzyme SETD8 in-vivo.
A. Validation was performed by running qRT-PCR products amplified using
primer pairs indicated on the schematic spanning exon 1 to exon 3 of histone
methyltransferase 8 gene. Amplification products of primers spanning exon 1 to
exon 3 were applied to polyacrylamide gel electrophoresis. No transcripts were
observed when reverse transcriptase was omitted from the reaction. PCR
products from control show, fully spliced transcripts while Son depleted samples
show transcripts in which exon 2 is skipped. Son-depleted samples showed a
major product shift from the fully spliced product to a product in which exon 2 is
skipped. The absence of Son causes exon skipping in this histone modifying
enzyme splice site selection in-vivo.
B. There was no change observed in transcripts levels between the Son depleted
RNA samples and control oligo transfected samples using GAPDH oligos as
internal control.
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CHAPTER 7
Discussion
Son and nuclear speckle integrity
Son was the largest SR protein identified in the proteomic analysis of
nuclear speckles (Saitoh et al., 2004). Here we have shown that Son depletion
causes all nuclear speckle components tested to reorganize into a doughnut
shaped phenotype not only in human HeLa cells but also in mouse NIH 3T3
cells. This is the first report in which depletion of a single protein has significantly
altered the organization of nuclear speckles. Son`s putative motifs may have
individual or additive functions in different pathways, and they may contribute to
communication among many subsets of functional machineries (transcription,
chromatin remodeling, and spliceosome) or molecules (splicing factors, substrate
RNA, and non-coding RNAs).
It has been suggested that the RS domains of nuclear speckle
components is important for their localization as well as important for nuclear
speckle self assembly by interaction of individual RS domains of speckle
components (Fu, 1995; Misteli, 2000). In case of Son deletion mutants our data
shows that our deletion mutant YFP-siR-Son N-Repeats (1-1493) which lacks the
RS domain was still able to localize to nuclear speckles. This could be because
the repeats are rich in serine and arginines which might behave similar to the RS
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domain of nuclear speckle components and could allow the localization of this
deletion mutant to nuclear speckles.
Our data suggests that the repeat region of Son is required for proper
nuclear speckle organization. It is possible that the repeats in Son could provide
a landing pad for pre-mRNA processing factors just like the heptad YSPTSPS
repeats in the CTD of the largest subunit of human RNA polymerase II provide a
landing pad for various pre-mRNA processing factors at the transcription site
(Bentley, 2005; Hirose et al., 2000; Lewis et al., 2000). Just as the pre-mRNA
processing factors loading from the CTD of the largest subunit of RNA Pol II to
the RNA is dependent on the phosphorylation and de-phosphorylation of the
serines present in the heptad repeats (Bentley, 2005; Hirose et al., 2000; Lewis
et al., 2000), the interaction between the nuclear speckle components and Son
could be dependent on having post-translational modification such as
phosphorylation of the serines and the threonines present in the repeats,
glycosylation of the arginines, and/or acetylation of lysine present in the repeats.
The putative RNA binding domains of Son have been recently shown by
our collaborators to have an important role in maintaining the localization of the
nuclear retained non coding RNA MALAT1 to nuclear speckles which has also
been implicated in maintaining structure of nuclear speckles (Tripathi et al.,
2010). Depletion of MALAT1 by RNAi changed localization of many splicing
factor proteins from nuclear speckles but did not change the localization of Son
(Tripathi et al., 2010). Son on the other hand was important for maintaining
localization of MALAT1 in nuclear speckles (Tripathi et al., 2010). This was
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shown by depleting endogenous Son using siRNA oligo 4 which changed the
localization of MALAT1 from nuclear speckles to a diffused nuclear localization.
This phenotype is very different from the phenotype observed by depletion of
other speckle components which reorganize in a doughnut shaped phenotype
after Son depletion. The rescue experiments performed using my YFP-siR-Son
construct and my other C-terminal deletion mutants showed that full-length YFPsiR-Son was able to protect the MALAT1 noncoding RNA localization in nuclear
speckles but none of the deletion mutants could (Tripathi et al., 2010). These
results suggest that the carboxy-terminal DS-RBD and the G-patch of Son are
required for localization and interaction with MALAT1. It is possible that the
repeat region of Son interacts with the proteins of nuclear speckles and the
putative RNA interacting regions are involved in interacting with the noncoding
RNAs such as MALAT1. Nuclear speckle components that depend on the
putative RNA binding domains for their localization possibly diffuse in the
nucleoplasm after Son depletion.
Depletion of Son perhaps severs the interaction between the proteins and
the RNA present in nuclear speckles leading to a change in morphology to a
doughnut shaped phenotype. It is also possible that Son forms the core or center
of nuclear speckles along with some noncoding RNAs such as MALAT1.
Depletion of Son therefore causes MALAT1 to localize to nucleoplasm and loss
of this core forms a center hole and the remaining nuclear speckle components
reorganize into doughnut shaped morphology because of their interaction
between the RS domains and polyadenylated RNA. The possibility that by
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depletion of Son we cause nuclear speckles to disrupt and the doughnuts that we
observe are transcription sites that are found at the periphery of the nuclear
speckles (Wei et al., 1999) can be ruled out as we did not see nascent transcripts
organize into doughnut shaped phenotype after Son depletion by Br-UTP
incorporation after Son depletion. It will be interesting to see by electron
microscopy what is in the center hole of the doughnut phenotype after Son
depletion.
Most pre-mRNA splicing component localization is dependent of RNA.
This was shown by treatment of RNAse leading to reorganization of speckle
components from nuclear speckles to a diffused nucleoplasmic localization,
whereas DNAse treatment had no affect (Spector et al., 1991). On the other
hand, preliminary results in the lab suggest that localization of Son is dependent
on DNA. This leads us to the possibility that Son which is classified as a DNA
binding protein (Sun et al., 2001), could probably bind to specific genomic
sequences and act as a seed for organizing nuclear speckles at these places in
the mammalian cells nucleus.
Our model is that Son might be a linker between individual interchromatin
granules, or splicing factor complexes in the nuclear speckles, thereby providing
a molecular scaffold to organize nuclear speckles. Son may bind to pre-mRNA
processing machinery or multimerize via its multiple novel repetitive motifs,
perhaps in a manner that is consistent with the self-assembly model for nuclear
speckle assembly. Son may provide an augmentation for assembly of nuclear
speckles along with the self assembly. Exogenous expression of the SR protein
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kinase Clk/STY completely disrupted nuclear speckle components leading to a
diffuse nuclear localization (Colwill et al., 1996; Sacco-Bubulya et al., 2002).
Ultrastructural analysis of nuclei in cells treated by overexpression of Clk/STY did
not reveal any apparent residual nuclear speckle scaffolding, such as a network
of filaments upon dispersal of splicing factors (Sacco-Bubulya et al., 2002).YFPKIAA1019 (Son) a 5` truncated clone of Son, also redistributed from nuclear
speckles to a diffuse nuclear distribution upon exogenous expression of Clk/STY,
possibly

indicating

that

serine/threonine

phosphorylation

regulates

the

distribution and/or function of Son (Saicco-Bubulya et al., 2002). The RS domain
of Son, or the serine residues in its tandem repeats, could be phosphorylated by
SR protein kinases suggesting that even if Son has a role in maintaining nuclear
speckle structural integrity it does not rule out the role of Son in other functions
similar to other SR proteins such as those involved in pre-mRNA processing.
Disruption in structure of nuclear speckles, the storage and assembly sites for
RNA processing factors, leads to inefficient pre-mRNA processing (SaccoBubulya et al., 2002). The effects of Son depletion on co-transcriptional premRNA processing is discussed later in this chapter.
Son and cell cycle progression
Reduction in the levels of other splicing factors have been implicated in
causing cell cycle arrest (Kittler et al., 2004; X. Li et al., 2005; Pacheco et al.,
2006). Reports from other labs have hinted at a role for Son in cell cycle but no
concrete arrest was shown (Ahn et al., 2008). We were first to show that Son
depletion leads to a mitotic arrest specifically at metaphase. Flow cytometery
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confirmed that Son depletion led to G2/M arrest as previously reported (Ahn et
al., 2008). Our cell growth studies have shown that Son depletion causes the
cells to stall in metaphase as compared to mock and control oligo transfected
cells. Our results of Son depletion causing a metaphase arrest have been further
validated by a subsequent publication (Huen et al., 2010). Consistent with our
results, a genome-scale RNAi screen to search for genes that altered mitotic
progression or caused mitotic defects identified Son as one of 2146 putative
proteins having this role (Kittler et al., 2004).
It is most likely that Son has a direct as well as indirect role in mitosis, as
many nuclear proteins have moonlighting roles during mitosis. Son was identified
in the proteomic analysis of human mitotic spindles (Sauer et al., 2005) and its
depletion causes shortening of mitotic spindles (Rines et al., 2008). Based on my
results, it is possible that Son is important for structural integrity of nuclear
speckles. Since nuclear speckle components begin to assemble into MIGs at
metaphase (Ferreira et al., 1994; Prasanth et al., 2003; Prasanth et al., 2003), it
is possible that MIGs may have some function during metaphase to promote cell
cycle progression. Recent data from our lab also shows that Son localizes to
MIGs (Keshia Torres-Munoz and Paula Bubulya, unpublished data) and therefore
may play an important role in structural assembly of MIGs. Son depletion may
somehow perturb assembly of MIGs, and therefore may cause arrest of cells at
metaphase. Also microscopic studies performed in our lab to study Son
localization through cell cycle indicate a weak labeling of Son at some
kinetochores (Keshia Torres-Munoz and Paula Bubulya, unpublished data)
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during metaphase suggesting that it may have a direct role during metaphase of
cell cycle. The fact that we observe Son labeling only on a few kinetochores and
it is weak may be because it is a transient localization and could be seen better
by observing Son’s cellular dynamics in living cells. Experiments in the lab are
underway to further investigate the direct role of Son during mitosis.
Splicing targets of Son and cell cycle
Changes observed in expression by exon array for some of the genes
may be because their expression is cell cycle dependent or because Son
depletion causes a change in expression of genes that are vital for cell cycle
progression. On the other hand Son may play a role in cell cycle by regulating
transcript levels or splice site selection of key mitotic regulators and thereby
affecting the mitotic process indirectly. An example of the latter shown here is
histone deacetylase 6 (HDAC6) which is not only implicated in managing the
acetylation levels of histones to regulate gene expression (Narlikar et al., 2002),
but it also deacetylates tubulin at lysine 40 and thereby influences the stability of
the microtubule network (Zhang et al., 2003; Zhao et al., 2010). Moreover
HDAC6 inhibition by an inhibitor induced degradation of both Aurora A and B
kinases through a proteasome-mediated pathway and induced a G2/M arrest.
Son depletion alters HDAC6 splicing as suggested by our results. Other such
examples involved in microtubule depolymerization which remain to be validated
include Katanin p80 subunit B1 (KATNB1) (Yu et al., 2005) and microtubule
associated protein 2 (MAP2) (Itoh et al., 2004). The exon array results suggest
that Son may also regulate mRNA levels and splicing
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of cyclin dependent

kinases, key regulators of transition between phases of cell cycle, such as CDK6
and CDK2 (Ekholm et al., 2000). The Appendix A of this document provides a lot
more examples that are implicated to play a role in cell cycle regulation but still
remain to be validated.
Repetetive sequences and co-transcriptional splicing
Expression of protein coding genes in mammals is complex because
processing of the premRNA is a co-transcriptional process that is orchestrated by
RNA polymerase II. Capping, splicing and polyadenalyation machinery is loaded
onto the CTD of the largest subunit of RNA Pol II and is transferred to nascent
transcripts as they emerge from the polymerase. The RNA Pol II CTD has 52
heptad repeats YSPTSPS (Bentley, 2005; Egloff et al., 2008; Hirose et al., 2000;
Lewis et al., 2000; Misteli et al., 1999; Phatnani et al., 2004; Rosonina et al.,
2004), and the phosphorylation status of serines at the various positions
including Ser2, Ser5, and Ser7 of the heptad repeats regulates the initiation,
elongation, and termination activation of RNA Pol II repeats (Brookes et al.,
2009; Meinhart et al., 2005; Phatnani et al., 2006).
Similar to the 52 heptad repeats YSPTSPS, one third of the primary amino
acid sequence of Son is made of novel repeats which are serine rich. For
example the 10 mer repeat with the concences sequence of MDSQMLASST is
tandemly repeated 10 times. It is a possibility that these repeats found in Son,
may be playing a similar role during co-transcriptional splicing by providing a

174

landing pad to various pre-mRNA processing factors until they are loaded on to
the CTD of RNA Pol II once transcription is initiated.
Son and transcription
Here we report that Son localizes to U2OS 2-6-3 inducible gene loci in the
inactive state. The localization of Son at the inactive gene locus suggests that it
may be playing an important role in transcription repression of this gene. If Son is
a transcriptional repressor for this gene locus, it would be interesting to see
whether Son depletion by itself would activate this gene locus in the absence of
doxycycline and pTetON. To this end we could deplete Son transcript levels
using Son siRNA oligos in these cells (Figure 46). Immunofluorescence
performed in the Son depleted U2OS 2-6-3 cells showed that Son antibodies did
not recognize any specific signal anywhere in the cells except at the locus
suggesting that Son was not depleted from the locus. Perhaps there is less turnover of Son at the locus as compared to Son that localizes to other parts of the
nucleus.
All SR proteins and splicing factors, examined thus far have been shown
to be recruited to the U2OS 2-6-3 inducible gene locus when transcription is
activated by addition of doxycycline (Janicki et al., 2004). It is not surprising to
see Son on the inactive U2OS 2-6-3 gene loci even though we implicate Son to
be involved in pre-mRNA processing, because the transcript produced at this
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Figure 46: Endogenous Son could not be depleted from the U2OS 2-6-3
gene locus.
U2OS 2-6-3 cells were transfected with CFP-LacI using electroporation and were
seeded on 6mwell dishes. The next day the cells were transfected with Control
oligonucleotides targeting luciferase (60 pmoles) (A-C), Son siGenome 4
oligonucleotides (60 pmoles) (D-F). Forty-eight hrs post transfection cells were
processed for immunofluorescence against Son and RNA was extracted from
duplicate wells.
A. Son transcript levels are reduced in Son siRNA transfected U2OS 2-6-3 cells
as compared to control oligo transfected cells when measured using qRT-PCR.
GAPDH was used as an internal control.
B.
(A) and (D): Panel show CFP-LacI localization which labels the Locus.
(B) and (E): Panels show Son immunolabeling using affinity purified WU13
(1:100) and FITC conjugated donkey anti-rabbit secondary antibody (1:500).
(C) and (F): Panels show merge to show co-localization of Son and Locus.
Endogenous Son is depleted from cells except at the locus (inset of panel E).
Son localizes to the locus when the locus is inactive (inset of panel C and F). Bar
= 5 µm.
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locus is only constitutively spliced and results from our beta-tropomyosin
minigene suggest that Son only plays a role in alternative splicing and not
constitutive splicing. It will be interesting to see if Son would localize to the active
locus if we replace the beta-globin minigene in this locus with the betatropomyosin minigene.
Son has been classified as a DNA binding protein and here we show that
it localizes to inactive heterochromatic DNA. It will be interesting to see whether
there are particular sequences where Son binds to at the U2OS 2-6-3 gene
locus. It will be tempting to look for similar concences sequences in-vivo as these
might be speckle seeding sequences.

Chromatin immuno-precipitation

experiments are being performed in our lab to identify which region of the U2OS
2-6-3 gene locus Son binds to. In addition to the U2OS 2-6-3 gene locus
experiments our exon array data suggest a number of endogenous genes
involved in various biochemical processes show a change in their transcriptional
activity after Son depletion.
Son and splice site selection
SR proteins are implicated in splice site selection as they are a part of the
exon definition complex of the spliceosome. They play a key role in identifying
and recruiting spliceosome complexes to weak splice sites by binding to exon
splicing enhancers or intron splicing enhancers and are antagonized by proteins
that bind ESS and ISS such as hnRNPs. A role for Son in pre-mRNA splicing has
been suggested by interaction of Son with a known splicing factor, SRrp53 which
plays a role in constitutive and alternative splicing (Cazalla et al., 2005). Here we
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show that Son depletion using RNAi causes a change in splice-site selection of
not only a constitutively expressed rat beta-tropomyosin minigene reporter
transcript but also several important endogenous transcripts.
Son localization, along with other splicing factors, to the constitutively
active transcription site of the stably integrated rat beta-tropomysosin minigene in
HeLa cells is consistent with the possibility that it could be involved in processing
of the RNA. The RNA recognition motifs (RRMs) of the SR proteins help them to
interact with the ESE and ISE regions of the nascent RNA, while the RS domain
is involved in recruiting the snRNPs to the splice site by protein-protein
interactions (Black, 2003; Jurica et al., 2003; Liu et al., 1998; Mayeda et al.,
1999; Wang et al., 2006; Zuo & Maniatis, 1996a). Most SR proteins are recruited
to transcription sites following phosphorylation of serines in the RS domain
(Bentley, 2005; Egloff et al., 2008; Hirose et al., 2000; Lewis et al., 2000; Misteli
et al., 1999; Phatnani et al., 2004; Rosonina et al., 2004). Interestingly,
localization of Son does not require Son`s putative RNA binding domain or the
RS domain. The YFP-Son siR (1-1493) which lacks these domains was
necessary to recruit Son to the rat beta-tropomyosin minigene RNA. This might
be possible because the repeat region of Son has many repeats that are rich in
serine for example the 10 mer MDSQMLASST and the RS rich repeat
SMMSSRS. This idea is further strengthened by the fact that YFP-Son siR (1332), which is the deletion mutant of Son that lacks the repeat region, could not
recruit to the rat beta-tropomyosin minigene RNA.
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Transient over expression of SF2/ASF leads to a higher inclusion of exon
6 than in normal HeLa cells transfected with the beta-tropomyosin minigene
(Caceres et al., 1994). This is very interesting as the same exon 6 is skipped
when we deplete Son in BTM HeLa cells suggesting that depletion of Son has
exactly opposite effects of over expression of SF2/ASF. It will be interesting to
see whether over expression of SF2/ASF would be able to compensate the
depletion of Son and lead to inclusion of exon 6. It would also be interesting to
see whether we could rescue the splice site selection defect by expressing YFPsiR-Son in the HeLa BTM cell line during RNAi.
Co-ordination of nuclear speckle structure, transcription, and splicing
Hyperphosphorylation

of

components

of

nuclear

speckles

by

overexpression of Clk/STY resulted in entirely diffuse nuclear localization of
splicing factors and defects in coordination between transcription and splicing
(Sacco-Bubulya et al., 2002). This suggests that maintaining the structural
integrity of nuclear speckles is important for coupling of transcription and
processing. Son depletion causes nuclear speckle components to re-organize
into a doughnut shaped phenotype suggesting that Son is important for
maintaining the localization of other pre-mRNA processing factors including
proteins and RNAs (Sharma et al., 2010) and the noncoding RNA MALAT1
(Tripathi et al., 2010). The reorganization after Son depletion does not affect the
localization of pre-mRNA processing factors such as U1-70K and SF2/ASF to the
rat beta-tropomyosin minigene. This might be because Son depletion does not
affect the protein expression level of these proteins but only reorganizes them
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(Sharma et al., 2010). This also strengthens our belief that the exon 6 skipping
that we observe is a direct result of Son depletion and not because the nuclear
speckle components reorganized after Son depletion. Son repeat region could
have functions both for maintaining nuclear speckle structure as well as
recruitment to the transcription site. The other regions of Son such as the
putative RNA binding regions and the RS domain perhaps are involved in other
functions such as interacting with RNA or DNA and other protein complexes.
Perhaps the repeat region provides a molecular scaffold like function at the
transcription site and helps the loading of RNA processing factors on the RNA
polymerase II CTD.
Perhaps the variable expression of Son seen on Northen blot analysis of
different tissues reflects a role of Son in regulating transcription and pre-mRNA
splicing of endogenous genes in the tissues where it is highly expressed. Son
expression was reported to be high in heart and brain. Examples in these tissues
are the cardiac muscle troponin (heart) and CDK5 (brain) mRNAs respectively
which show changes in level after Son depletion.

Splicing impact on epigenetics
Recently Son was identified as one of the top ten genes (in a genome
wide screen) involved in maintaining self-renewal and pluripotency of human
embryonic stem cells (Chia et al., 2010). It is possible that Son regulates gene
expression, either at the level of transcription or by performing splice site
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selection of other epigenetic factors important for regulating these functions.
Epigenetic factors such as SetD8 which regulates gene expression in a cell cycle
dependent manner by mono-methylation of histone 4 at Lys20 (H4K20me1) to
promote chromosome condensation (David, 2010) and ADA which has been
implicated in yeast to be a part of a histone acetyl transferase complex (HAT)
(Grant et al., 1997) are two such genes validated here which support this idea.
In addition to these two genes HDAC6 discussed above also has been shown to
have histone deacetylase activity (Narlikar et al., 2002). There are more genes
implicated by our exon array data that have a role in epigenetic regulation which
show significant changes after Son depletion. Other examples include genes
involved in DNA methylation such as methyltransferase 1(DNMT1) and DNA
methyltransferase 1-associated protein 1 (DMAP1) (Rountree et al., 2000), or
transcription repressors such as B-cell lymphoma 6 (BCL6) (Ahmad et al., 2003)
and MYST histone acetyltransferase (monocytic leukemia) 4 (MYST4) (McGraw
et al., 2007) and many others that remain to be validated listed in Appendix B of
this document.
It remains to be seen whether the regulation of Son seen at the level of
transcription and splicing by exon array translates to modified protein abundance
and/or sequence or whether it leads to mRNA degradation. Does Son bind to
RNA at specific consensus sequences such ESEs or ISEs just like the other SR
proteins to regulate splice site selection? These and many other questions about
the role of Son protein remain to be answered and provide fertile ground for
further research in the lab.
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Cell Cycle Regulators
Symbol
CCNG1
CDC25A
CDC6
CDK2
CDK6
CDKN1A
CLK1

Fold
change

Description

Cyclin-G1
3.364124
M-phase inducer
phosphatase 1
-2.86678
Cell division control
protein 6 homolog
2.08945
Cell division protein kinase
2
2.7082
Cell division protein kinase
6
3.896559
Cyclin-dependent kinase
inhibitor 1
2.14393
Dual specificity protein
kinase CLK1
2.053146

p-value
0.001073
9.66E-05
0.007626
3.09E-05
1.06E-06
2.70E-05
0.008173

CRIP1

Cysteine-rich protein 1

-2.18095

0.0194

CRIP2

Cysteine-rich protein 2
Macrophage colonystimulating factor 1
Precursor
C-terminal-binding protein
2
Cystathionine gammalyase

-2.05052

0.00054

1.439651

0.014375

2.218502

1.47E-05

3.086065

8.35E-05

Catenin beta-1
Growth-regulated alpha
protein Precursor

2.275175

3.23E-05

2.371574

0.001475

Protein CYR61 Precursor
DNA damage-inducible
transcript 3

-2.63152

0.000542

4.237314

0.015976

-3.47564

0.001322

2.320252

4.03E-06

CSF1
CTBP2
CTH
CTNNB1
CXCL1
CYR61
DDIT3
DHPS
DKC1

Deoxyhypusine synthase
H/ACA ribonucleoprotein
complex subunit 4
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DNMT1

DNA (cytosine-5)methyltransferase 1

-2.21151

2.98E-06

2.250151

0.008014

2.389455

0.000305

-2.87743

2.66E-05

-2.25048

2.22E-07

2.806594

8.32E-05

-2.28295

0.000267

2.815136

0.000568

MDM2

Transcription factor E2F7
Epidermal growth factor
receptor kinase substrate
8
Histone acetyltransferase
PCAF
Katanin p80 WD40containing subunit B1
Microtubule-associated
protein 2
Dual specificity mitogenactivated protein kinase
kinase 6
Microtubule-associated
serine/threonine-protein
kinase 4
E3 ubiquitin-protein ligase
Mdm2

2.806512

0.000224

TUBA1A

Tubulin alpha-1A chain

-2.03935

0.000284

E2F7
EPS8
KAT2B
KATNB1
MAP2
MAP2K6
MAST4
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Cell Cycle Regulators
Symbol

Description

Exon/Intron

Action

p-value

CDC2L6

Cell division cycle
2-like protein
kinase 6

Exon2

exon-skipping

5.19E-05

Exon7

exon-inclusion

1.22E-05

Exon9

exon-skipping

0.002526

CSF1

Cysteine-rich
protein 2
Macrophage
colonystimulating factor
1 Precursor

DNMT1

DNA (cytosine-5)methyltransferase
1

Exon1

exon-inclusion

0.000859

CDK10

Cell division
protein kinase 10

Exon4

exon-skipping

0.000756

CDC2L2

CDC2 like 2

Exon15

exon-inclusion

0.001546

CENPT

Centromere
protein T

Exon5

exon-inclusion

0.000178

Exon4

exon-skipping

0.000756

Exon8

exon-inclusion

0.004913

Exon5

exon-inclusion

0.000158

Exon3

exon-inclusion

0.000898

Exon11

exon-skipping

0.001704

Exon14

exon-skipping

0.000779

Exon5

exon-skipping

5.02E-06

CRIP2

CDC45L

Cell division
protein kinase 10
CDC45-related
protein

TUBB6

Tubulin beta-6
chain

CDK10

MAP2

Tubulin alpha-1A
chain
Microtubuleassociated
protein 2
Microtubuleassociated
protein 2

TUBG2

Tubulin gamma-2
chain

TUBA1A
MAP2

187

TUBA1A

Tubulin alpha-1A
chain

Exon4
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exon-inclusion

3.97E-06

Appendix B

189

Transcription Regulators
Symbol

Description

Fold change

p-value

BCL6

B-cell lymphoma 6 protein

2.315834571

3.16E-05

DMAP1

DNA methyltransferase 1-associated protein 1

-1.67800714

0.0003487

DNMT1

DNA (cytosine-5)-methyltransferase 1

-2.21150789

2.98E-06

HEMK1

HemK methyltransferase family member 1

-1.96591272

1.34E-06

MYST4

Histone acetyltransferase MYST4

2.131041046

6.68E-05

HIST1H3A

Histone H3.1

-2.07885048

0.0114687

SETD4

SET domain-containing protein 4

1.057570031

0.7310539

SETD6

SET domain-containing protein 6

1.106912445

0.0362198

SETD1B

Histone-lysine N-methyltransferase SETD1B

1.233324396

0.0013963

SETD5

SET domain-containing protein 5

1.309031923

0.016918

SETD2

Histone-lysine N-methyltransferase SETD2

1.407826941

0.0092394

SETDB1

Histone-lysine N-methyltransferase SETDB1

1.580204564

0.0036794

SETD7

Histone-lysine N-methyltransferase SETD7

1.681031393

0.0013267

SETD8

Histone-lysine N-methyltransferase SETD8

2.198500277

0.0001461

SETDB2

Histone-lysine N-methyltransferase SETDB2

-1.23564595

0.0483965

HDAC4

Histone deacetylase 4

1.285461499

0.000336

HDAC9

Histone deacetylase 9

1.484561301

0.0014156

HDAC7

Histone deacetylase 7

-1.67541675

2.26E-05
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HDAC3

Histone deacetylase 3

-1.64402632

0.0074939

HDAC5

Histone deacetylase 5

-1.56856511

0.0014161

HDAC4

Histone deacetylase 4

1.285461499

0.000336
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Transcription Regulators
Symbol

SETD8

Description
DNA methyltransferase 1associated protein 1
DNA (cytosine-5)methyltransferase 1
HemK methyltransferase
family member 1
Histone acetyltransferase
MYST4
SET domain-containing
protein 6
Histone-lysine Nmethyltransferase SETD8

HDAC6

Histone deacetylase 6

Exon26

exon-skipping

8.50E-05

HDAC6

Histone deacetylase 6
Histone-arginine
methyltransferase CARM1

Exon27

exon-skipping

1.9E-04

Exon15

exon-skipping

8.18E-05

DMAP1
DNMT1
HEMK1
MYST4
SETD6

CARM1
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Exon/Intron

Action

p-value

Exon7

exon-inclusion

4.4E-03

Exon1

exon-inclusion

8.37E-04

Exon10

exon-inclusion

1.37E-05

Intron1

exon-skipping

1.87E-04

Intron3

exon-inclusion

4.38E-05

Exon2

exon-skipping

4.1E-04
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